<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neuroinflammation</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neuroinflammation</journal-id>
<journal-title-group>
<journal-title>Journal of Neuroinflammation</journal-title>
</journal-title-group>
<issn pub-type="epub">1742-2094</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31952509</article-id>
<article-id pub-id-type="pmc">6969442</article-id>
<article-id pub-id-type="publisher-id">1705</article-id>
<article-id pub-id-type="doi">10.1186/s12974-020-1705-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The progress of gut microbiome research related to brain disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Sibo</given-names>
</name>
<address>
<email>sibozhu@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yanfeng</given-names>
</name>
<address>
<email>yfyf518@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Kelin</given-names>
</name>
<address>
<email>xukelin@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Mei</given-names>
</name>
<address>
<email>cuimei@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Weimin</given-names>
</name>
<address>
<email>Weimin.Ye@ki.se</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Genming</given-names>
</name>
<address>
<email>gmzhao@shmu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Li</given-names>
</name>
<address>
<email>lijin@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Xingdong</given-names>
</name>
<address>
<email>xingdongchen@fudan.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution>State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0626 5341</institution-id><institution-id institution-id-type="GRID">grid.452350.5</institution-id><institution>Fudan University Taizhou Institute of Health Sciences, </institution></institution-wrap>Taizhou, China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution>Department of Epidemiology, School of Public Health, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution>School of Data Science, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution>Department of Neurology, Huashan Hospital, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Department of Medical Epidemiology and Biostatistics, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution>Human Phenome Institute, </institution><institution>Fudan University, </institution></institution-wrap>825 Zhangheng Road, Shanghai, 201203 China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>17</volume>
<elocation-id>25</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">There is increasing evidence showing that the dynamic changes in the gut microbiota can alter brain physiology and behavior. Cognition was originally thought to be regulated only by the central nervous system. However, it is now becoming clear that many non-nervous system factors, including the gut-resident bacteria of the gastrointestinal tract, regulate and influence cognitive dysfunction as well as the process of neurodegeneration and cerebrovascular diseases. Extrinsic and intrinsic factors including dietary habits can regulate the composition of the microbiota. Microbes release metabolites and microbiota-derived molecules to further trigger host-derived cytokines and inflammation in the central nervous system, which contribute greatly to the pathogenesis of host brain disorders such as pain, depression, anxiety, autism, Alzheimer’s diseases, Parkinson’s disease, and stroke. Change of blood–brain barrier permeability, brain vascular physiology, and brain structure are among the most critical causes of the development of downstream neurological dysfunction. In this review, we will discuss the following parts:
<list list-type="bullet"><list-item><p id="Par2">Overview of technical approaches used in gut microbiome studies</p></list-item><list-item><p id="Par3">Microbiota and immunity</p></list-item><list-item><p id="Par4">Gut microbiota and metabolites</p></list-item><list-item><p id="Par5">Microbiota-induced blood–brain barrier dysfunction</p></list-item><list-item><p id="Par6">Neuropsychiatric diseases
<list list-type="bullet"><list-item><p id="Par7">■ Stress and depression</p></list-item><list-item><p id="Par8">■ Pain and migraine</p></list-item><list-item><p id="Par9">■ Autism spectrum disorders</p></list-item></list></p></list-item><list-item><p id="Par10">Neurodegenerative diseases
<list list-type="bullet"><list-item><p id="Par11">■ Parkinson’s disease</p></list-item><list-item><p id="Par12">■ Alzheimer’s disease</p></list-item><list-item><p id="Par13">■ Amyotrophic lateral sclerosis</p></list-item><list-item><p id="Par14">■ Multiple sclerosis</p></list-item></list></p></list-item><list-item><p id="Par15">Cerebrovascular disease
<list list-type="bullet"><list-item><p id="Par16">■ Atherosclerosis</p></list-item><list-item><p id="Par17">■ Stroke</p></list-item><list-item><p id="Par18">■ Arteriovenous malformation</p></list-item></list></p></list-item><list-item><p id="Par19">Conclusions and perspectives</p></list-item></list></p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Gut microbiome</kwd>
<kwd>Metabolite</kwd>
<kwd>Neuropsychiatric disorders</kwd>
<kwd>Neurodegenerative disorders</kwd>
<kwd>Cerebrovascular diseases</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>National Key Research and Development program of China</institution>
</funding-source>
<award-id>2017YFC0907002, 2017YFC0907501</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81502870, 31521003</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012326</institution-id>
<institution>International Science and Technology Cooperation Programme</institution>
</institution-wrap>
</funding-source>
<award-id>2014DFA32830</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the Key Basic Research Grants from Science and Technology Commission of Shanghai Municipality, China</institution>
</funding-source>
<award-id>16JC1400500</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003399</institution-id>
<institution>Science and Technology Commission of Shanghai Municipality</institution>
</institution-wrap>
</funding-source>
<award-id>2017SHZDZX01</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par75">Since Rober Koch first developed a bacterial culture technique in the laboratory [<xref ref-type="bibr" rid="CR1">1</xref>], Theodour Escherich identified the common gut bacillus <italic>Escherichia coli</italic> [<xref ref-type="bibr" rid="CR2">2</xref>], and Élie Metchnikoff found an association between longevity and microbes from dairy food [<xref ref-type="bibr" rid="CR3">3</xref>], an increasing number of commensal and pathogenic bacteria have been discovered and characterized as exerting a profound influence on human health and behaviors through food digestion, fermentation, metabolism, and vitamin production.</p>
<p id="Par76">In the past five years, gut microbiota research has become a research“hot spot,” and more than 25,000 gut microbiota-related articles have been published (as of 1st Sep 2019). Using next-generation sequencing (NGS) approaches, large-scale studies such as the Human Microbiome Project (HMP) and the Metagenomics of the Human Intestinal Tract (MetaHIT) project have provided essential references regarding the microbiota composition in human bodies [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Biomarkers in the gut are related to a variety of diseases, including metabolic disorders [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], inflammatory bowel diseases (IBD) [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], a variety of cancers [<xref ref-type="bibr" rid="CR10">10</xref>], and even disorders of the central neural system.</p>
<p id="Par77">Researchers have identified alterations in the composition of the gut microbiota related to several symptoms or diseases, such as pain, cognitive dysfunction, autism [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], neurodegenerative disorders, and cerebral vascular diseases [<xref ref-type="bibr" rid="CR13">13</xref>]. The microbiota of different habitats contribute to bidirectional brain-gut signaling through humoral, neural, and immunological pathogenic pathways [<xref ref-type="bibr" rid="CR14">14</xref>]. The central nervous system (CNS) alters the intestinal microenvironment by regulating gut motility and secretion as well as mucosal immunity via the neuronal-glial-epithelial axis and visceral nerves [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. Extrinsic factors, including dietary habit, lifestyle, infection, and early microbiota exposure, as well as intrinsic factors such as genetic background, metabolite, immunity, and hormone, regulate the composition of gut microflora. On the other hand, bacteria react to these changes by producing neurotransmitters or neuromodulators in the intestine to impact the host CNS. These modulators include bacteria-derived choline, tryptophan, short-chain fatty acids (SCFAs), and intestinally released hormones such as ghrelin or leptin (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Dysregulation of the gut microbiota in brain disorders. Extrinsic and intrinsic factors shape the composition of gut microbiota and further contribute to brain disorders, including cognitive dysfunction, neurodegeneration, and cerebrovascular diseases</p></caption><graphic id="MO1" xlink:href="12974_2020_1705_Fig1_HTML"></graphic></fig></p>
<p id="Par78">Herein, we will review the progress in gut-brain axis studies and explain how changes in the gut microbiota alter cognitive function, cerebrovascular physiology, and the development of neurological and neuropsychiatric diseases.</p>
</sec>
<sec id="Sec2">
<title>Technical approaches in gut microbiome studies</title>
<p id="Par79">Current technologies do not allow the cultivation of all bacteria isolated from the gut. Two widely adopted culture-free approaches have been devised to effectively quantify and characterize the microbiome, i.e., targeted sequencing and metagenomic sequencing. Targeted sequencing is also referred to as marker gene sequencing [<xref ref-type="bibr" rid="CR20">20</xref>] including 16S ribosomal RNA (rRNA), internal transcribed spacer (ITS), and 18S rRNA sequencing. In 1977, Woese et al. inferred phylogenetic relationships between prokaryotic organisms using the rRNA small subunit (SSU) genes; this approach was later proven to also work well in eukaryotes [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Wilson and Blitchington showed a good agreement of the diversity and 16S rRNA sequences between quantitative cultured cells and direct PCR-amplified bacteria from a human fecal specimen [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
<p id="Par80">Researchers now can use this powerful tool to sequence 16S rRNA for assessing microbial taxonomy and diversity from various human specimens.</p>
<p id="Par81">However, 16S rRNA sequencing achieves only ~ 80% accuracy in the genus level and is not able to fully resolve taxonomic profiles at the species level or strain level, especially with short read lengths [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Shotgun sequencing was then developed for the comprehensive profiling of the DNA from microbiota. In 1998, Handelsman et al. first coined the term “metagenome” when cloning DNA fragments from soil-derived biosamples into bacterial artificial chromosomal vectors [<xref ref-type="bibr" rid="CR26">26</xref>]. In 2002, using the shotgun sequencing approach, Breitbart et al. sequenced a viral metagenome that did not carry rDNAs, and more than 65% of the species that they identified had not been reported previously [<xref ref-type="bibr" rid="CR27">27</xref>]. The same year witnessed the isolation of the antibiotics Turbomycin A and B from a metagenomic library of soil microbial DNA by Gillespie et al. using a restriction enzyme approach [<xref ref-type="bibr" rid="CR28">28</xref>]. In 2004, Tyson et al. sequenced biofilms using random shotgun sequencing and determined single-nucleotide polymorphisms at the strain level. It is now understood that the metagenome represents a collection of DNA from the environment, and shotgun sequencing has been widely adopted for metagenomic sequencing [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p id="Par82">Other technologies including metatranscriptomics [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], metaproteomics [<xref ref-type="bibr" rid="CR32">32</xref>], and metabolomics [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], can be applied to investigate RNAs, proteins, and metabolites in metagenome-wide association studies (MWAS). The MWAS approach has shown great potential not only in the identification of the microbiome taxonomy but also in the annotation of functions, pathways, and metabolism.</p>
</sec>
<sec id="Sec3">
<title>Gut microbiome and host immunity</title>
<p id="Par83">The human microbiota interacts with the host gut immune system for mutual adaptation and immune homeostasis by tolerating commensal antigens [<xref ref-type="bibr" rid="CR35">35</xref>]. The perturbation of gut microbiota could lead to a higher incidence of autoimmunity and allergy [<xref ref-type="bibr" rid="CR36">36</xref>]. Both innate immunity and adaptive immunity in the human gastrointestinal tract play critical roles as guardians that maintain pathogen-host homeostasis. In terms of innate immunity, pathogen-associated molecular patterns (PAMPs) were first suggested to describe the pathogenic targets recognized by pattern recognition receptors (PRRs) from the host innate immune system [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. PAMPs represent “molecular signatures” of a pathogen class, such as the highly conserved microbial structures consisting of lipopolysaccharides (LPS), lipoteichoic acid (LTA), CpG, or dsRNAs. Gut microbes and their derivatives constantly interact with PRRs in intestinal epithelial cells, immune cells in peripheral blood, and even cells in the CNS. Microbiota dysbiosis has been reported to trigger gut barrier dysfunctions, such as changes in tight junctions, mucous layers, and secretion of immunoglobulin A and intraepithelial lymphocytes [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. In the rodent model, hippocampal neurogenesis is proved to be controlled by the stimulation of toll-like receptors (TLRs). TLR2 is responsible for neurogenesis, while TLR4 exhibits a contrary function [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. By LPS binding, TLR4 inhibits retinal neurogenesis and differentiation via MyD88-dependent and NF-κB signaling pathways [<xref ref-type="bibr" rid="CR43">43</xref>]. TLR2 activation also inhibits the proliferation of embryonic neural progenitor cells [<xref ref-type="bibr" rid="CR44">44</xref>]. The downstream inflammatory cytokine TNF-α further reduces neurogenesis and induces the proliferation of astrocytes [<xref ref-type="bibr" rid="CR45">45</xref>]. There is also evidence that TLR4 is related to the development of learning and memory [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p>
<p id="Par84">On the other hand, adaptive immunity routinely plays a crucial role in both anti-infection functions and the maintenance of microbiota-host homeostasis to prevent overreaction to harmless antigens. This balance is mainly accomplished by mutual regulation between regulatory T cells and TH17 intestinal lamina propria [<xref ref-type="bibr" rid="CR48">48</xref>]. Regulatory T cells (Tregs) are crucial in the maintenance of immune homeostasis. The protective immunosuppression signals are delivered through GATA3, Foxp3, and IL-33 expression in regulatory T cells. SCFAs from dietary fiber are produced by Clostridia species, in particular, contributing to the activation and expansion of CD4+Foxp3+ Treg cells [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. The polysaccharide endocytosed by dendritic cells could promote expansion and differentiation of naïve T cells into Th1 and regulatory T cell subsets [<xref ref-type="bibr" rid="CR51">51</xref>]. Gut microbiota-activated TH17 cells, characterized by IL-17A, IL-17F, and IL-22 secretion, are responsible for high-affinity IgA secretion, memory CD4+ T cell differentiation and anti-<italic>Staphylococcus aureus</italic> function [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. However, dysbiosis of gut bacteria activates T and B cells and further influences the secretion and class switching of IgA in B cells, the differentiation of TH17 cells, and the further recruitment of dendritic cells, group 3 innate lymphoid cells (ILC3) and granulocytes [<xref ref-type="bibr" rid="CR48">48</xref>]. When TH17 cells are induced by inflammatory signals such as IL-23 overexpression, these cells are likely to be associated with autoimmune diseases, including uveitis and encephalomyelitis [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR59">59</xref>]. Brain lesions in the hypothalamus-pituitary-adrenal gland axis (HPA) can alter intestinal immunity. In a mouse stroke model, a significant reduction of T and B cells in Peyer’s patches is observed 24 h after stroke [<xref ref-type="bibr" rid="CR60">60</xref>]. In turn, impairment of the blood–brain barrier (BBB) following stroke is triggered by microbiota changes and immune dysregulation, further allowing brain infiltration of immune cells to react to CNS tissues [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
</sec>
<sec id="Sec4">
<title>Microbiota altered blood–brain barrier and brain structure</title>
<p id="Par85">BBB is a semipermeable barrier composed of specialized endothelial cells in the microvasculature [<xref ref-type="bibr" rid="CR62">62</xref>]. The BBB separates the CNS from the peripheral blood [<xref ref-type="bibr" rid="CR63">63</xref>]. There are a variety of disorders related to microbial-induced BBB dysfunction, which may cause anxiety, depression, autism spectrum disorders (ASDs), Parkinson’s disease, Alzheimer’s disease, and even schizophrenia [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR66">66</xref>]. The exact mechanism whereby the microbiota affects BBB physiology remains unknown. Possible mechanisms include BBB modulation by gut-derived neurotransmitters and bacterial metabolites. Rodent models have shown that a loss of the normal intestinal microbiota results in increased permeability of the BBB, while a pathogen-free gut microbiota restores BBB functionality [<xref ref-type="bibr" rid="CR67">67</xref>]. Metabolic diseases such as diabetes can result in increased permeability of the BBB and, potentially, further progression to Alzheimer’s disease with amyloid-β peptide deposition [<xref ref-type="bibr" rid="CR64">64</xref>]. Microbiota dysbiosis has been found to alter the protective functions of the BBB, including regulation of permeability [<xref ref-type="bibr" rid="CR67">67</xref>] through tight junction expression [<xref ref-type="bibr" rid="CR68">68</xref>] or further behavioral changes [<xref ref-type="bibr" rid="CR69">69</xref>].</p>
<p id="Par86">The microbiota composition is also correlated with brain morphology. A germ-free mouse model demonstrated that the microbiota is required for the normal development of hippocampal and microglial morphology [<xref ref-type="bibr" rid="CR70">70</xref>]. Structural magnetic resonance imaging (MRI) revealed that the patient’s cortical thickness is negatively correlated with the duration of Crohn’s disease [<xref ref-type="bibr" rid="CR71">71</xref>]. The posterior regions and middle frontal gyrus have also been found to be reduced in adolescent patients [<xref ref-type="bibr" rid="CR72">72</xref>]. The relative abundance of Actinobacteria is correlated with better organization of the amygdalar, hypothalamic, and thalamic microstructure according to MRI. The changes in structure are associated with better motor speed, attention, and cognitive test scores [<xref ref-type="bibr" rid="CR73">73</xref>].</p>
</sec>
<sec id="Sec5">
<title>Food and food-derived metabolites</title>
<p id="Par87">As the second-largest metabolic organ in the human body, the gut harbors approximately 1.5 kg of colonized microbiota and metabolic mass from food [<xref ref-type="bibr" rid="CR74">74</xref>]. The diet pattern plays an essential role in the composition of gut microflora and affects psychiatric conditions such as depression and anxiety [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. Diets rich in fruits, whole grains, vegetables, and fish have been proved to be beneficial to brain function such as the lower risk of dementia by reducing gut inflammation and neurodegeneration [<xref ref-type="bibr" rid="CR77">77</xref>]. By far, several well-known “Mediterranean-like” dietary patterns have shown neuroprotective effects, i.e., Mediterranean diet (MeDi), Dietary Approach to Stop Hypertension (DASH) diet, and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Patients with Alzheimer’s disease (AD) and atherosclerosis benefit from these “Mediterranean-like” diets [<xref ref-type="bibr" rid="CR79">79</xref>]. On the other hand, diet rich in saturated fatty acids, animal proteins, and sugars have been shown to increase the risk of brain dysfunction. A high-fat diet (HFD), or namely “Western” diet, is normally regarded as detrimental to the brain [<xref ref-type="bibr" rid="CR80">80</xref>]. Excessive intake of HFD is associated with increases in <italic>Firmicutes</italic> and <italic>Proteobacteria</italic> and a decrease in <italic>Bacteroidetes</italic> [<xref ref-type="bibr" rid="CR81">81</xref>]. HFD also induces plasma and fecal levels of acetate, triggers the overproduction of insulin and ghrelin, and further promotes overfeeding [<xref ref-type="bibr" rid="CR82">82</xref>]. Obesogenic effects and inflammation caused by HFD can be reduced by uptake of polyphenols from fruits, accompanied with an increase in <italic>A. muciniphila.</italic></p>
<p id="Par88">The food can quickly alter the microbiota composition in the gut. Changing to a high-fat or high-sugar dietary pattern from a low-fat or plant fiber-rich dietary pattern can shift of the microbiome even within one day [<xref ref-type="bibr" rid="CR83">83</xref>]. A dog experiment revealed that the proportion of carbohydrate and protein was responsible for the change [<xref ref-type="bibr" rid="CR84">84</xref>]. The <italic>Bacteroides</italic> abundance was reported to be associated with animal-derived protein and saturated fats, while <italic>Prevotella</italic> was associated with carbohydrates and simple sugars [<xref ref-type="bibr" rid="CR85">85</xref>]. Vegetable-based diets can increase SCFAs, accompanied by elevated <italic>Prevotella</italic> and some fiber-degrading <italic>Firmicutes</italic> [<xref ref-type="bibr" rid="CR86">86</xref>]. When fed with fructose, <italic>Bacteroidetes</italic> was significantly decreased in the mice model, while <italic>Proteobacteria</italic>, <italic>Firmicutes,</italic> and pathogenic <italic>Helicobacteraceae</italic> were significantly increased [<xref ref-type="bibr" rid="CR87">87</xref>].</p>
<p id="Par89">Food patterns and dietary habits result in a change of brain physiology which can be explained by food-derived metabolites (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Metabolites derived from food play important roles in the pathogenesis of brain-related diseases. Recent findings showed the food-derived metabolites include not only SCFAs but also phosphatidylcholine, trimethylamine oxide (TMAO), L-carnitine, glutamate, bile acids, lipids, and vitamins. The food derivatives and microbe-fermented small molecular metabolites are released by gut microbiota into the blood which interacts with the host and further contributes to a variety of disorders, including brain diseases.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Dietary metabolism and roles of the gut microbiota. Dietary habit and food pattern result in the formation of gut microbiota and in turn modulate the host inflammation and thrombosis, by which the brain disorders are induced</p></caption><graphic id="MO2" xlink:href="12974_2020_1705_Fig2_HTML"></graphic></fig></p>
<p id="Par90">The metabolism of phosphatidylcholine which is rich in poultry, egg, and especially red meat, has been reported to involve a crucial biological interaction between the gut microbiota and host [<xref ref-type="bibr" rid="CR88">88</xref>]. This pathway includes TMAO, a product of the oxidation of trimethylamine (TMA), which is produced during the metabolism of red meat-derived L-carnitine [<xref ref-type="bibr" rid="CR89">89</xref>]. The levels of TMAO, betaine, and choline have been shown to serve as predictors in the diagnosis and prognosis of cardiovascular diseases [<xref ref-type="bibr" rid="CR90">90</xref>–<xref ref-type="bibr" rid="CR92">92</xref>]. These gut microbiota-derived metabolites induce and promote foam cell formation via cholesterol accumulation in macrophages. Recent studies have revealed that the <italic>Clostridiales, Lachnospiraceae</italic>, and <italic>Ruminococcus</italic> are highly correlated with the area of atherosclerotic lesion and TMAO levels in the plasma. Interestingly, an analog of choline, 3,3-dimethyl-1-butanol (DMB), was shown to inhibit the formation of TMAO in microbes [<xref ref-type="bibr" rid="CR93">93</xref>]. An increased abundance of <italic>Enterobacteriaceae</italic> and <italic>Ruminococcus</italic> is found in atherosclerotic cardiovascular disease patients compared to controls, while butyrate-producing bacteria, including <italic>Roseburia</italic> and <italic>Faecalibacterium</italic>, are relatively depleted in these patients [<xref ref-type="bibr" rid="CR94">94</xref>].</p>
<p id="Par91">A highly ketogenic diet, with a high-fat, adequate-protein, and low-carbohydrate composition, has been shown to exert an anti-seizure effect [<xref ref-type="bibr" rid="CR95">95</xref>]. This high-fat, low-carbohydrate pattern is associated with <italic>Akkermansia</italic> and <italic>Parabacteroides</italic> and results in a higher seizure threshold by reducing serum gamma-glutamylated amino acid levels and increasing brain GABA/glutamate levels [<xref ref-type="bibr" rid="CR95">95</xref>]. On the other hand, a high-fat and high-cholesterol diet (HFHC) induces dyslipidemia and triggers the small intestine mucosal immune system, further promoting inflammation and altering the gut microflora [<xref ref-type="bibr" rid="CR96">96</xref>]. The phylum <italic>Firmicutes</italic> is positively correlated with carbohydrate oxidation, while <italic>Bacteroidetes</italic> exhibits a negative correlation. Herbal dietary supplements such as Rhizoma Coptidis alkaloids have been shown to alleviate hyperlipidemia in a mouse model by modulating the gut microflora and bile acid pathways [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p id="Par92">A high-fiber diet has been reported to improve brain health through multiple effectors [<xref ref-type="bibr" rid="CR98">98</xref>]. In the mammalian gut, dietary fiber is degraded by bacteria to produce long-chain fatty acids (LCFAs) and SCFAs as metabolites [<xref ref-type="bibr" rid="CR99">99</xref>]. LCFAs, including lauric acid, promote the differentiation of TH17 cells. The LCFAs are known as trigger factors in the establishment of autoimmune encephalomyelitis model [<xref ref-type="bibr" rid="CR100">100</xref>]. In contrast, SCFAs usually not only serve as energy sources for epithelial cells but also recruit and expand regulatory T cells and release modulatory cytokines [<xref ref-type="bibr" rid="CR101">101</xref>]. SCFAs are mainly composed of acetate (40–60%), propionate (20–25%) and butyrate (15–20%) [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>]. Acetate and propionate are produced by the Bacteroidetes phylum in particular, while species of the Firmicutes phylum preferentially produce large amounts of butyrate [<xref ref-type="bibr" rid="CR104">104</xref>]. Systemic loss of SCFAs, especially acetate, is likely to exacerbate inflammatory reactions in germ-free mice, whereas direct acetate drinking is helpful to ameliorate disease by decreasing the level of the inflammatory mediator myeloperoxidase [<xref ref-type="bibr" rid="CR105">105</xref>]. Propionic acid protects the mouse model from autoimmune colitis better than other SCFAs through the induction of Treg cells [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]. A high-fiber diet inducing butyrate production can protect the brain well and enhance neuron plasticity in a neurogenesis model [<xref ref-type="bibr" rid="CR98">98</xref>]. It is worth noting that SCFA can manipulate the acetylation and methylation state and further regulating the host’s gene expression and metabolic processes [<xref ref-type="bibr" rid="CR106">106</xref>]. For example, lower abundances of SCFAs are shown associated with a lower degree of chromatin acetylation [<xref ref-type="bibr" rid="CR107">107</xref>].</p>
<p id="Par93">Dietary tryptophan is an essential source of an aryl hydrocarbon receptor (AHR) agonist that limits CNS inflammation by reducing both astrocyte and microglial pathogenic activities and experimental autoimmune encephalomyelitis (EAE) development [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. Tryptophan is usually metabolized by a bacterial tryptophanase (TnAse) from the gut microbiota to generate indole, indole-3-propionic acid (IPA), and indole-3-aldehyde (IAld). Indole is a precursor of the AhR agonist indoxyl-3-sulfate (I3S) [<xref ref-type="bibr" rid="CR110">110</xref>]. Recently, dietary tryptophan was reported to protect mice against multiple sclerosis [<xref ref-type="bibr" rid="CR108">108</xref>]. However, it has also been indicated that a high level of indole in a rat model increases the likelihood of developing brain dysfunctions, including anxiety and mood disorders [<xref ref-type="bibr" rid="CR111">111</xref>].</p>
<p id="Par94">Szczesniak et al. found that bacteria such as Faecalibacterium, Alistipes and Ruminococcus were correlated with depression, as well as the level of isovaleric acid, a type of volatile fatty acid (VFA) [<xref ref-type="bibr" rid="CR112">112</xref>]. These associations probably occur because gut-derived VFAs can pass the BBB and further interact with synaptic neurotransmitters. Interestingly, Wu et al. revealed that although the plasma metabolome of vegans is significantly different from that of omnivores, the microbiota composition of these groups is similar [<xref ref-type="bibr" rid="CR113">113</xref>].</p>
<p id="Par95">One of the dietary tyrosine metabolites, 4-ethylphenylsulfate (4-EPS), is able to induce autism spectrum disorder (ASD)-like behaviors. However, following injection with <italic>Bacteroides fragilis</italic>, the gut microbiota produces reduced levels of neurotoxic metabolites, including 4-EPS, serum glycolate, and imidazole propionate, correcting gut permeability and ameliorating anxiety-like behavior [<xref ref-type="bibr" rid="CR114">114</xref>].</p>
</sec>
<sec id="Sec6">
<title>Neuropsychiatric dysfunction</title>
<p id="Par96">Mood, memory, and cognition were originally thought to be exclusively regulated by the CNS due to a variety of extrinsic factors such as hormonal fluctuations [<xref ref-type="bibr" rid="CR115">115</xref>]. It is now becoming clear that many non-nervous system factors, including the immune system and the resident bacteria of the gastrointestinal tract, regulate not only our feelings and how we form, process, and store memories but also cognitive function-related microstructure and morphology. Psychogastroenterological studies have been performed to analyze the microbiota regulating resilience, optimism, mindfulness, and self-regulation and mastery [<xref ref-type="bibr" rid="CR116">116</xref>]. Alteration of the gut microbiota regulates not only the synthesis of metabolites but also different neuroactive molecules and central neurotransmitters, such as melatonin, gamma-aminobutyric acid (GABA), serotonin, histamine, and acetylcholine [<xref ref-type="bibr" rid="CR117">117</xref>]. Germ-free and antibiotic rodent models have shown that microbiota exposure can induce depression, anxiety and stress, decreases in social communication, increases in exploratory activity, and memory deterioration (Table <xref ref-type="table" rid="Tab1">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Rodent models in mood disorders and cognitive function research</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Animal</th><th>Model type</th><th>Phenotype and effect (vs. controls)</th></tr></thead><tbody><tr><td>NMRI mice</td><td>Germ-free</td><td>Increased motor activity and reduced anxiety [<xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td>Wistar rat</td><td><p>Application of probiotics:</p><p><italic>Lactobacillus helveticus</italic> R0052 and <italic>Bifidobacterium longum</italic> R0175</p></td><td>Decreased stress-induced gastrointestinal discomfort and anxiolytic effect [<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td>Balb/c mice</td><td><p>Application of probiotics:</p><p><italic>Lactobacillus rhamnosus</italic> (JB-1)</p></td><td>Increase of corticosterone, GABA receptor, <italic>N</italic>-acetyl aspartate and glutamate; reduced stress-induced corticosterone and anxiety- and depression-related behavior [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td>Balb/c mice</td><td>Germ-free, SPF and <italic>B. infantis</italic> mice</td><td>GF mice exhibited exaggerated HPA stress response and decreased BDNF compared to SPF mice, but can be reversed with <italic>B. infantis</italic> [<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td>Swiss Webster mice</td><td>Germ-free</td><td>GF mice have a anxiolytic behavior, increased BDNF and reduced serotonin 1A receptor in dentate gyrus of the hippocampus [<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>Balb/c mice and AKH mice</td><td><italic>T. muris</italic> infection and application of probiotics <italic>B. longum</italic> NCC3001</td><td>Infection with <italic>T. muris</italic> induced anxiety-like behavior and decreased level of BNDF. Treatment with <italic>B. longum</italic> reverses the effect and normalizes BDNF level [<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td>Balb/c mice and NIH mice</td><td>Germ-free and SPF with antibiotics</td><td>Increased exploratory behavior and hippocampal expression of BDNF in hippocampus [<xref ref-type="bibr" rid="CR124">124</xref>]</td></tr><tr><td>Stress-sensitive F344 Rat</td><td>Germ-free and SPF</td><td>Decreased social interaction in GF mice [<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td>Swiss Webster mice</td><td>Germ-free</td><td>Significant social impairments and decreased social preference in GF mice [<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td>Wistar rat</td><td>Application of antibiotic</td><td>Reduced social interactions in offsprings when antibiotic is applied peri-conceptionally [<xref ref-type="bibr" rid="CR127">127</xref>]</td></tr><tr><td>Swiss Webster mice</td><td>Germ-free</td><td>Increased exploratory in GF mice [<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>Swiss Webster mice</td><td>Application of antibiotic</td><td>Increased exploratory behavior in antibiotic-treated mice [<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td>C57BL/6 mice</td><td>Application of antibiotic</td><td>Decreased working memory in antibiotic-treated SPF mice; no effect on spatial memory [<xref ref-type="bibr" rid="CR128">128</xref>]</td></tr><tr><td>Swiss Webster mice</td><td>Germ-free</td><td>Decreased working memory in GF mice [<xref ref-type="bibr" rid="CR129">129</xref>]</td></tr><tr><td>C57BL/6 mice</td><td>SPF</td><td>Decreased working memory in antibiotic-treated SPF mice [<xref ref-type="bibr" rid="CR130">130</xref>]</td></tr><tr><td>C57BL/6 mice and CF1 mice</td><td><italic>Citrobacter rodentidum</italic> infection</td><td>Increase anxiety and memory dysfunction [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]</td></tr></tbody></table></table-wrap></p>
<p id="Par97">Early life is an important period in the development of the nervous system of the host. The microbiota colonizes the host immediately after birth within a few weeks and forms organ-specific niches [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. The initial commensal microbiota gradually forms similar communities in adults in the following 2–3 years [<xref ref-type="bibr" rid="CR134">134</xref>]. However, the process can be influenced by inflammation during this stage. As an important modulator of neurogenesis, microglia may play an inflammatory and detrimental role in neural development when activated by LPS. Such effects result in abnormal host behaviors and learning impairments later in adulthood [<xref ref-type="bibr" rid="CR135">135</xref>]. The microbiota can facilitate the development of host neurological functions (i.e., the development of cognitive functions and memory). In a mouse model, long-term exposure to a western diet has been shown to not only cause obesity but also trigger systemic inflammatory responses to LPS and to further induce cognitive deficits such as poorer spatial memory [<xref ref-type="bibr" rid="CR136">136</xref>]. Magnusson et al<italic>.</italic> indicated that high-energy food alters the composition of the microbiota and impacts working memory and cognitive flexibility, resulting in poorer long-term memory formation [<xref ref-type="bibr" rid="CR137">137</xref>]. Infection by bacteria such as <italic>C. rodentium</italic> is another trigger that may generate stress-induced memory dysfunction in a rodent model [<xref ref-type="bibr" rid="CR129">129</xref>].</p>
<sec id="Sec7">
<title>Stress and depression</title>
<p id="Par98">The gut microbiota has been shown to play critical roles in the pathogenesis of depression and anxiety-like behavior [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]. Abnormal HPA hyperactivity in response to stress is associated with depressive episodes. Sudo et al. found that the HPA stress response is hyperactive in germ-free mice, but this hyperactivity can be reversed by <italic>Bifidobacterium infantis</italic> [<xref ref-type="bibr" rid="CR121">121</xref>]. Plasma ACTH and corticosterone levels have been observed to be higher in GF mice than SPF mice when responding to stress. However, Diaz et al. revealed that GF mice exhibit increased plasma levels of tryptophan and serotonin compared with SPF mice [<xref ref-type="bibr" rid="CR61">61</xref>], which is correlated with increased motor activity and reduced anxiety. Neufeld et al.’s results also demonstrated that GF mice exhibit anxiolytic behavior via increased expression of brain-derived neurotrophic factor (BDNF) and reduced serotonin 1A receptor levels in the hippocampus [<xref ref-type="bibr" rid="CR122">122</xref>]. Anxiety and depression are typical complications in irritable bowel syndrome (IBS) patients, who show a higher prevalence of these conditions than healthy controls [<xref ref-type="bibr" rid="CR140">140</xref>]. In addition to anxiety and depression, IBD patients exhibit mild verbal memory dysfunctions. The VFA isovaleric acid has been regarded as an important mediator of depression [<xref ref-type="bibr" rid="CR112">112</xref>]. Gut-derived isovaleric acid can cross the BBB and interfere with synaptic neurotransmitter release. Isovaleric acid is positively correlated with saliva cortisol, which is strongly associated with depression in boys [<xref ref-type="bibr" rid="CR141">141</xref>]. Bravo et al. have shown that GABA receptor expression in different brain areas can be altered by chronic treatment with <italic>Lactobacillus rhamnosus.</italic> This treatment further reduces stress-induced corticosterone levels and depression-like behaviors [<xref ref-type="bibr" rid="CR119">119</xref>]. Stress-induced reduction of hippocampal neurogenesis can also be prevented by a probiotic combination of <italic>Lactobacillus helveticus</italic> strain R0052 and <italic>Bifidobacterium longum</italic> strain R0175 [<xref ref-type="bibr" rid="CR142">142</xref>]. De Theije et al. showed that the effect of probiotics is highly strain specific. The administration of <italic>Campylobacter jejuni</italic> promotes depressive- or stress-like behaviors, while <italic>Bifidobacterium</italic> strains exert a decreasing effect on these behaviors [<xref ref-type="bibr" rid="CR143">143</xref>].</p>
</sec>
<sec id="Sec8">
<title>Autism spectrum disorder</title>
<p id="Par99">ASDs are characterized by abnormal communication and social behaviors, which begin in early childhood neurodevelopment. Gut problems or a history of gastrointestinal perturbations such as infection and anti- or pro-biotic intake in early childhood contributes to the disease development [<xref ref-type="bibr" rid="CR144">144</xref>–<xref ref-type="bibr" rid="CR146">146</xref>]. Gastrointestinal discomfort in ASD patients is usually thought to have a neurologic rather than a gastroenteric cause [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR148">148</xref>]. However, recent studies have revealed that gut microflora alteration-related gastrointestinal symptoms are associated with mucosal inflammation [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. Anti-inflammatory and SCFA-synthesizing species such as <italic>Faecalibacterium</italic> species are decreased in ASD patients compared to controls [<xref ref-type="bibr" rid="CR150">150</xref>]. Oral administration of <italic>Bacteroides fragilis</italic> (a commensal bacterium) can correct intestinal epithelial permeability caused by dysbiosis, leading to the modulation of several metabolites and ameliorated symptoms of ASD [<xref ref-type="bibr" rid="CR114">114</xref>]. The Firmicutes/Bacteroides ratio and the composition of Fusobacteria or Verrucomicrobia are associated with ASDs. Lower levels of <italic>Bifidobacteria</italic> species, mucolytic bacteria, and <italic>Akkermansia muciniphila</italic> are found in children with ASD, while <italic>Lactobacillus</italic>, <italic>Bacteroides</italic>, <italic>Prevotella</italic>, and <italic>Alistipes</italic> are present at higher levels [<xref ref-type="bibr" rid="CR145">145</xref>, <xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. However, <italic>Desulfovibrio</italic> species, <italic>Bacteroides vulgatus</italic>, and Clostridia are over-represented in children with ASD with gastrointestinal symptoms compared with normal subjects with similar GI complaints [<xref ref-type="bibr" rid="CR153">153</xref>, <xref ref-type="bibr" rid="CR154">154</xref>]. One hypothesis regarding the reoccurrence of ASD symptoms after oral vancomycin treatments is that Clostridia undergo spore formation to avoid eradication [<xref ref-type="bibr" rid="CR145">145</xref>]. Although there is little direct causal evidence that the microbiota can cure ASD, the use of probiotic strains of <italic>Lactobacillus</italic> species and <italic>Bifidobacterium</italic> species has been shown to ameliorate gastrointestinal symptoms in children with ASD [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR155">155</xref>]. Hsiao et al.’s research suggested that oral treatment with <italic>Bacteroides fragilis</italic> in a mouse model altered the microbial composition, improved gut permeability, and reduced defects in communicative and anxiety-like behaviors [<xref ref-type="bibr" rid="CR114">114</xref>].</p>
</sec>
<sec id="Sec9">
<title>Pain and migraine</title>
<p id="Par100">Pain is common in the general population, and the microbiota has shown to impact several types of pain, including spinal visceral pain in IBS [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR156">156</xref>] and small intestinal bacterial overgrowth (SIBO) [<xref ref-type="bibr" rid="CR157">157</xref>] as well as migraine [<xref ref-type="bibr" rid="CR158">158</xref>] and sometimes headache [<xref ref-type="bibr" rid="CR159">159</xref>]. Administration of antibiotics may induce gut dysbiosis and alter host-bacterial interactions, leading to colonic sensory and motor changes in a mouse model. These effects can be reflected by nociceptive markers such as CB2 and TLR7 [<xref ref-type="bibr" rid="CR160">160</xref>]. Amaral et al. showed that inflammatory hypernociception induced by LPS, TNF-α, IL-1beta, and the chemokine CXCL1 is reduced in germ-free mice. This effect was similar to the induction by prostaglandins and dopamine [<xref ref-type="bibr" rid="CR161">161</xref>]. It has been revealed by meta-analyses that <italic>Helicobacter pylori</italic> infection is associated with migraine [<xref ref-type="bibr" rid="CR162">162</xref>]. Faraji et al. performed a randomized blinded clinical trial that demonstrated improvement of migraine associated with <italic>H. pylori</italic> eradication [<xref ref-type="bibr" rid="CR158">158</xref>]. A recent study revealed that gut microbiota dysbiosis-induced chronic migraine-like pain are accomplished by up-regulating TNF-α level [<xref ref-type="bibr" rid="CR163">163</xref>].</p>
<p id="Par101">On the other hand, visceral pain can be effectively alleviated by probiotic treatment in animal models. Rousseaux et al. found that analgesic functions could be achieved by taking specific <italic>Lactobacillus</italic> strains orally. The resulting morphine-like effect was shown to be mediated by enhanced expression of intestinal epithelial μ-opioid and cannabinoid receptors [<xref ref-type="bibr" rid="CR164">164</xref>]. Probiotic <italic>B. infantis</italic> 35624 and <italic>Lactobacillus farciminis</italic> were shown to exert visceral antinociceptive effects by altering central sensitization in rat models [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>]. <italic>L. farciminis</italic> can also attenuate stress-induced Fos expression in the spine, which explains the antinociceptive effect of this probiotic. In a clinical-alimentary study, O’Mahony et al. treated patients with probiotics and found that <italic>Lactobacillus salivarius</italic> UCC4331 significantly reduced pain and discomfort during the administration phase for one week, while <italic>B. infantis</italic> 35624 reduced pain and discomfort scores during both the administration and washout phases [<xref ref-type="bibr" rid="CR167">167</xref>].</p>
</sec>
</sec>
<sec id="Sec10">
<title>Neurodegenerative diseases</title>
<p id="Par102">Neurodegenerative diseases are a collection of neurological diseases that are characterized by progressive loss of neurons, including AD, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) [<xref ref-type="bibr" rid="CR168">168</xref>]. Each of the neurodegenerative diseases has been reported to have unique pathologies and clinical features. Nevertheless, neuroinflammation and higher intestinal permeability are common characteristics of them [<xref ref-type="bibr" rid="CR169">169</xref>]. Some of the peripheral inflammation factors such as TNF-α, iNOS, and IL-6 have been validated in the pathogenesis of the neurodegeneration in CNS [<xref ref-type="bibr" rid="CR170">170</xref>, <xref ref-type="bibr" rid="CR171">171</xref>]. In this chapter, we will discuss how functional gastrointestinal disorders are critically linked to these neuropathies.</p>
<sec id="Sec11">
<title>Parkinson’s disease</title>
<p id="Par103">PD is a typical neurodegenerative disorder affecting more than 1% of the population over 65 years of age [<xref ref-type="bibr" rid="CR172">172</xref>]. PD is thought to be caused by the interaction between environmental and genetic risk factors. This neuropathology is characterized by motor deficits and non-motor symptoms (NMS), which ultimately have an impact on quality of life [<xref ref-type="bibr" rid="CR173">173</xref>].</p>
<p id="Par104">Recently, the gut microflora has drawn increasing attention with respect to how it may be implicated in PD [<xref ref-type="bibr" rid="CR173">173</xref>]. A variety of enteral dysfunctions are associated with PD, such as SIBO, malnutrition, <italic>H. pylori</italic> infection, and constipation [<xref ref-type="bibr" rid="CR174">174</xref>]. In terms of the role of GI tracts pathology in PD, a higher frequency of α-synuclein detection is found in the patients than in controls from many researches [<xref ref-type="bibr" rid="CR175">175</xref>]. Animal studies validated that resection of vagus nerve can stop transmission of α-synuclein from gastro intestine to the CNS [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR176">176</xref>]. Bowel inflammation can also trigger neuroinflammation to promote dopaminergic neuronal loss in the rodent substantia-nigra tissue [<xref ref-type="bibr" rid="CR177">177</xref>]. Forsyth and colleagues found that “leaky guts” and bowel inflammation affect the progression of PD [<xref ref-type="bibr" rid="CR178">178</xref>]. The increased colonic permeability was found to be correlated with increased α-synuclein and <italic>E. coli</italic> accumulation in the sigmoid of PD patients [<xref ref-type="bibr" rid="CR179">179</xref>].</p>
<p id="Par105">Counts of butyrate-producing and anti-inflammatory bacterial genera such as <italic>Blautia</italic>, <italic>Coprococcus</italic>, and <italic>Roseburia</italic> are significantly lower in PD patients, while those of LPS-producing genera <italic>Oscillospira</italic> and <italic>Bacteroides</italic> are significantly higher [<xref ref-type="bibr" rid="CR180">180</xref>]. The pro-inflammatory genus <italic>Ralstonia</italic> is significantly abundant in PD patient mucosae, implying that the inflammatory gut barrier is pathogenic. Scheperjans et al. revealed that the altered intestinal microbiota and the related motor phenotype could be applied to the diagnosis of PD [<xref ref-type="bibr" rid="CR181">181</xref>]. The relative abundance of Prevotellaceae is significantly reduced in PD and has been validated as a very sensitive biomarker for PD diagnosis. A model based on multiple bacterial families and constipation status was shown to present 90.3% specificity in PD diagnosis. Ingestion of fermented milk for 4 weeks was proven to be effective in improving PD complications such as constipation [<xref ref-type="bibr" rid="CR182">182</xref>]. Two studies have shown that anti-TNF therapy and immunosuppressants reduced PD risk [<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR184">184</xref>]. However, there is very limited clinical evidence of the beneficial effects of probiotics in the treatment of PD and further evidences are needed.</p>
</sec>
<sec id="Sec12">
<title>Alzheimer’s disease</title>
<p id="Par106">AD, which is the most common degenerative disease, is characterized by a decline in cognitive skills, including memory, language, and problem solving, eventually resulting in dementia [<xref ref-type="bibr" rid="CR185">185</xref>]. AD is pathologically characterized by neuroinflammation, accumulation of beta-amyloid (Aβ) plaque, and neurofibrillary tau tangles in the brain. Aβ (Aβ40 or Aβ42) are cleaved products from the amyloid precursor protein (APP). The Aβ polymerizes into fibrils in the CNS by self-aggregation and further triggers inflammation and neurotoxicity. Recent studies have demonstrated the role and impact of microbial dysfunction and infection on the aetiology of AD, especially the activation of neuroinflammation and the formation of amyloids.</p>
<p id="Par107">Neuroinflammation factors, including IL-1beta, IL-6, and TNF-alpha, have been observed in AD patients [<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR187">187</xref>]. Gareau et al.’s work implied that memory loss and dysfunction are exacerbated by infection under exposure to acute stress [<xref ref-type="bibr" rid="CR129">129</xref>]. Released LPS triggers the inflammation and promotes amyloid fibrillogenesis in the brain [<xref ref-type="bibr" rid="CR188">188</xref>]. The microglia can recognize amyloid molecules by TLR4 and TLR2 for clearance. Interestingly, signaling of myeloid differentiation primary response 88 (MyD88) from microglial TLR2 is responsible for activation of TNF-α and nuclear factor kappa B (NF-κB) which also induces the formation of Aβ by promoting α-secretase and β-secretase, respectively [<xref ref-type="bibr" rid="CR189">189</xref>].</p>
<p id="Par108">As a generic term, amyloid denotes any insoluble, aggregation-prone, and lipoprotein-rich deposit that resembles carbohydrate starches [<xref ref-type="bibr" rid="CR190">190</xref>]. Bacterial metabolites and products have recently been shown to worsen AD. In AD patients, bacteria-derived amyloids (curli, tau, Aβ, α-syn, and prion) can function as initiators to cross-seed and aggregate host amyloids [<xref ref-type="bibr" rid="CR191">191</xref>]. Amyloids such as CsgA and Aβ42 can exhibit cerebral deposition and trigger a cascade of AD-related pathological events despite their dissimilarity of sequences [<xref ref-type="bibr" rid="CR192">192</xref>]. It is reported that chronic <italic>H. pylori</italic> could trigger the release of both inflammatory mediators and amyloids in AD patients [<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR194">194</xref>]. <italic>H. pylori</italic> filtrate was shown to have the ability to induce the hyperphosphorylation of tau protein in a cell model [<xref ref-type="bibr" rid="CR195">195</xref>]. <italic>E. coli</italic> has been reported to produce extracellular amyloids known as curli fibres, a major subunit of CsgA. Other amyloids produced by microbes include CsgA produced by <italic>Salmonella</italic> spp., FapC by <italic>Pseudomonas fluorescens</italic>, MccE492 by <italic>Klebsiella pneumonia</italic>, phenol-soluble Modulins by <italic>Staphylococcus aureus</italic>, TasA by <italic>Bacillus subtills</italic>, and Chaplins by <italic>Streptomyces coelicolor</italic> [<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR196">196</xref>, <xref ref-type="bibr" rid="CR197">197</xref>]. Harach et al. found a remarkable shift in the gut microbiota in fecal samples from an APP-transgenic mouse and reported that the microbiota contributed to the development of this neurodegenerative diseases. Intestinal germ-free APP transgenic mice were found to have a reduction of cerebral amyloid pathology compared to controls [<xref ref-type="bibr" rid="CR198">198</xref>]. More recently, <italic>Chlamydia pneumoniae</italic> infection in astrocytes has been demonstrated to be involved in the generation of β-amyloid, which promotes AD [<xref ref-type="bibr" rid="CR199">199</xref>]. Ingestion of probiotics has been reported to be beneficial in AD. Azm S et al. demonstrated that <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> were effective in ameliorating memory and learning dysfunction in a β-amyloid-injected rodent model [<xref ref-type="bibr" rid="CR200">200</xref>]. Wang and Liang et al. revealed that <italic>Lactobacillus fermentum</italic> NS9 and <italic>Lactobacillus helveticus</italic> NS8 alleviated ampicillin-induced spatial memory impairment and improved the spatial memory of chronic restraint stress [<xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR202">202</xref>]. In a randomized clinical trial of probiotic treatment conducted in 60 AD patients, Akbari et al. showed that after 12 weeks of administration of <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> species via fermented milk, mini-mental state examination (MMSE) scores improved significantly. Improvements in glucose and lipid metabolism were also observed, which were thought to enhance the cognitive assessment scoring [<xref ref-type="bibr" rid="CR203">203</xref>]. The elimination of <italic>Helicobacter pylori</italic> by triple eradication therapy results in improvement of cognition parameters in AD patients [<xref ref-type="bibr" rid="CR204">204</xref>]. It is promising that the use of pro- or antibiotics could be future therapeutic agents for AD. It has been demonstrated in a recent study that exercise and probiotics could reduce Aβ plaques in the hippocampus, improve cognitive performance, and finally, attenuate the development of Alzheimer's disease in the mouse model [<xref ref-type="bibr" rid="CR205">205</xref>].</p>
</sec>
<sec id="Sec13">
<title>Amyotrophic lateral sclerosis</title>
<p id="Par109">ALS is a fatal neurodegenerative disorder that affects the brain and spinal cord neurons and typically results in death. Most ALS patients die within 3 to 5 years due to respiratory paralysis [<xref ref-type="bibr" rid="CR206">206</xref>]. The pathogenesis of ALS is proposed to be outcomes of genetic-environmental interactions. Studies on interactions between innate immune response and LPS have provided essential evidences of ALS pathogenesis [<xref ref-type="bibr" rid="CR207">207</xref>–<xref ref-type="bibr" rid="CR209">209</xref>]. More than a decade ago, it was proposed that gut-derived neurotoxins, including tetanus and botulinum toxins produced by <italic>Clostridia</italic> species, cause ALS [<xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]. “Leaky gut” is also likely to be responsible for ALS [<xref ref-type="bibr" rid="CR212">212</xref>]. More recently, Wu’s ALS mouse model revealed that the tight junction structure was damaged and that gut permeability was increased. Gut dysbiosis is also found in ALS mice, particularly in terms of reduced levels of butyrate-producing bacteria, including <italic>Butyrivibrio fibrisolvens</italic> and <italic>E. coli</italic> [<xref ref-type="bibr" rid="CR213">213</xref>]. In the gut of ALS patients, butyrate-producing <italic>Oscillibacter</italic>, <italic>Anaerostipes</italic>, and <italic>Lachnospira</italic> counts were found to be reduced, while that of glucose-metabolizing <italic>Dorea</italic> was significantly increased [<xref ref-type="bibr" rid="CR214">214</xref>]. Brenner et al. found the richness of OTUs to be significantly higher in an ALS group compared with a control group. However, the relative ratio of <italic>Bacteroidetes/Firmicutes</italic> did show a significant difference between ALS patients and controls [<xref ref-type="bibr" rid="CR215">215</xref>]. Supplementation of the diet with 2% butyrate in drinking water in an ALS mouse model resulted in improved gut integrity and survival [<xref ref-type="bibr" rid="CR216">216</xref>]. Mazzini et al. revealed unique bacterial profiles in ALS patients compared to the controls. Higher <italic>E. coli</italic> and <italic>Enterobacteria</italic> abundance, and lower <italic>Clostridium</italic> was found in ALS participants [<xref ref-type="bibr" rid="CR217">217</xref>]. These results imply that anti-inflammatory SCFAs produced by gut microbiota are potential therapeutic agents affecting ALS progression. Mazzini et al. further conducted a clinical trial of bacteriotherapy aimed at understanding the effect of <italic>Lactobacillus</italic> strains [<xref ref-type="bibr" rid="CR217">217</xref>]. However, more direct evidence and results are needed to clarify how the gut microbiota improves or aggravates ALS.</p>
</sec>
<sec id="Sec14">
<title>Multiple sclerosis</title>
<p id="Par110">MS is a type of autoimmunity-induced neurodegenerative disease in the spinal column and CNS. The environmental factors contribute profoundly to pathogenesis of this demyelinating disease, including obesity, smoking, viruses, and vitamin D [<xref ref-type="bibr" rid="CR218">218</xref>]<bold>.</bold> Alterations in the microbiome and prevalence of “leaky gut” have been found in MS patients and experimental autoimmune encephalomyelitis (EAE) animal, the most commonly used inflammatory demyelinating disease model [<xref ref-type="bibr" rid="CR219">219</xref>, <xref ref-type="bibr" rid="CR220">220</xref>]. The immunological changes in EAE are characterized by increasing proinflammatory cell infiltration and impaired Treg function [<xref ref-type="bibr" rid="CR221">221</xref>]. The favorable gut microbiota can regulate permeability of BBB, limit astrocyte pathogenicity, and activate microglia [<xref ref-type="bibr" rid="CR222">222</xref>]. In the EAE model, the <italic>Bifidobacterium</italic> and lactic acid-producing bacteria such as of <italic>Lactobacillus</italic> are able to reduce severity of EAE symptoms [<xref ref-type="bibr" rid="CR223">223</xref>, <xref ref-type="bibr" rid="CR224">224</xref>]. The abundance of Archaea is high in MS while <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic> phyla are lower or even depleted [<xref ref-type="bibr" rid="CR218">218</xref>]. The <italic>Bacteroides</italic> and <italic>Clostridia</italic> species are especially responsible for the induction of FoxP3+ Tregs in suppression of inflammation [<xref ref-type="bibr" rid="CR222">222</xref>]. One small longitudinal study found that the gut microbiota profiles, especially <italic>Fusobacteria</italic> were associated with future relapse risk in MS [<xref ref-type="bibr" rid="CR225">225</xref>]. <italic>Psuedomonas</italic>, <italic>Haemophilus</italic>, <italic>Blautia</italic>, and <italic>Dorea</italic> genera were detected to be increased in MS patients, while <italic>Parabacteroides</italic>, <italic>Adlercreutzia</italic> and <italic>Prevotella</italic> genera were much lower [<xref ref-type="bibr" rid="CR219">219</xref>]. <italic>Clostridiales</italic> order were restored after MS treatment with glatiramer acetate including <italic>Bacteroidaceae</italic>, <italic>Faecalibacterium</italic>, <italic>Ruminococcus</italic>, <italic>Lactobacillaceae</italic>, and <italic>Clostridium</italic> [<xref ref-type="bibr" rid="CR226">226</xref>]. Ochoa-Reparaz et al. unraveled that oral administration of antibiotics can delay the pathogenesis of EAE. However, intraperitoneal injection did not significantly impact the outcomes [<xref ref-type="bibr" rid="CR227">227</xref>]. This implies changes in intestinal microbiota ecosystem are associated with MS development. Other studies also validated that probiotic treatment and fecal microbial transplantation can achieve similar effect [<xref ref-type="bibr" rid="CR228">228</xref>, <xref ref-type="bibr" rid="CR229">229</xref>].</p>
</sec>
</sec>
<sec id="Sec15">
<title>Cerebral vascular diseases</title>
<p id="Par111">Cerebrovascular diseases are a variety of circulatory diseases that affect cerebral circulation and, thus, cause brain damage. The most common presentations of cerebrovascular disease are ischemic stroke, hemorrhagic stroke, and intracranial arteriovenous malformation (AVM). The GI microflora and infection have been indicated to impact the host immune system and ischemic stroke processes. Infection and inflammation at plaque lesions along with imbalanced carnitine, cholesterol and fat metabolism by intestinal microflora ultimately contributed to atherosclerosis.</p>
<sec id="Sec16">
<title>Atherosclerosis</title>
<p id="Par112">Fernandes et al. revealed that oral <italic>Streptococcus mutans</italic> is ubiquitous in the atherosclerotic plaques of patients with vascular disease [<xref ref-type="bibr" rid="CR230">230</xref>]. Apfalter et al. identified traces of <italic>Chlamydia pneumoniae</italic> in carotid artery atherosclerosis using a nested PCR-based approach [<xref ref-type="bibr" rid="CR231">231</xref>]. Mitra et al.’s metagenomic study of carotid atherosclerosis plaques showed that 2–16% of the sequencing reads from plaque tissue came from bacteria, including <italic>Lactobacillus rhamnosus</italic> and <italic>Neisseria polysaccharea</italic>. The bacterial content is higher in patients with ischemic symptoms. <italic>Acidovorax</italic> spp. and <italic>H. pylori</italic> cells were also detected by fluorescence in situ hybridization (FISH) in atherosclerotic tissue [<xref ref-type="bibr" rid="CR232">232</xref>]. Karlsson et al. sequenced the gut metagenomes of patients with symptomatic atherosclerosis and healthy subjects. The genus <italic>Collinsella</italic> was observed to be enriched in carotid stenotic patients, whereas <italic>Roseburia</italic> and <italic>Eubacterium</italic> were more abundant in healthy controls [<xref ref-type="bibr" rid="CR233">233</xref>].The gut microbiota has been suggested to transform dietary choline, lecithin, or carnitine into TMAO and, thus, cause vascular atherosclerosis by affecting lipid and hormonal homeostasis [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR234">234</xref>]. The carnitine-butyrobetaine-trimethylamine-<italic>N</italic>-oxide pathway has been found to be associated with carotid atherosclerosis [<xref ref-type="bibr" rid="CR235">235</xref>]. Stimulation of monocyte by LPS can be a critical step of the formation of foam cell in atherosclerotic plaque by either inducing inflammation or triggering LDL uptake [<xref ref-type="bibr" rid="CR236">236</xref>, <xref ref-type="bibr" rid="CR237">237</xref>]. A series of probiotic-based therapy attempts have been in progress, including human trials using <italic>L. acidophilus</italic> 145, <italic>B. longum</italic> 913 [<xref ref-type="bibr" rid="CR238">238</xref>], <italic>L. acidophilus</italic> and <italic>B. bifidum</italic> [<xref ref-type="bibr" rid="CR239">239</xref>] to restore HDL/LDL ratio, and mouse experiments using <italic>L. plantarum ZDY04</italic> against TMAO [<xref ref-type="bibr" rid="CR240">240</xref>].</p>
</sec>
<sec id="Sec17">
<title>Stroke</title>
<p id="Par113">Benakis et al. showed that infarction-induced ischemic brain injury could be reduced by antibiotic administration. The antibiotic-induced alterations in the gut microbiota could increase regulatory T cells and decrease IL-17+ γδ T cells, which suppress the trafficking of effector T cells after stroke. Interestingly, the gut microbiota-associated infarction model can be transmitted and reproduced by fecal transplantation [<xref ref-type="bibr" rid="CR241">241</xref>]. Systemic exposure to <italic>Porphyromonas gingivalis</italic> has been linked to an increased risk of ischemic stroke [<xref ref-type="bibr" rid="CR242">242</xref>]. Kawato et al. revealed that continual venous injection of Gram-negative bacteria might accelerate stroke in SHRSP (spontaneously hypertensive stroke-prone) rats, probably due to LPS-induced oxidative stress responses [<xref ref-type="bibr" rid="CR243">243</xref>]. Zhu et al. discovered that TMAO is associated with platelet hyperactivity and thrombosis risk [<xref ref-type="bibr" rid="CR90">90</xref>]. Their following study validated in a short-term cohort that an omnivorous diet could generate a higher TMAO content in blood than was induced by a vegan diet, which was more likely to promote the formation of blood clots. Their study suggested that the use of low doses of aspirin was helpful to alleviate platelet aggregation caused by TMAO [<xref ref-type="bibr" rid="CR244">244</xref>]. Yin et al. revealed that opportunistic gut-derived pathogens such as <italic>Enterobacter</italic>, <italic>Megasphaera</italic>, <italic>Oscillibacter</italic>, and <italic>Desulfovibrio</italic> were enriched in patients experiencing stroke and transient ischemic attack, whereas beneficial genera including <italic>Bacteroides</italic>, <italic>Prevotella</italic>, and <italic>Faecalibacterium</italic> were less abundant. Paradoxically, Yin et al. showed that TMAO levels were lower in patients than in controls [<xref ref-type="bibr" rid="CR245">245</xref>].</p>
</sec>
<sec id="Sec18">
<title>Arteriovenous malformation</title>
<p id="Par114">There is no direct causal relationship between the microbiota and AVM onset in humans, while animal models have implied a pivotal role of the microflora in AVM pathophysiology and pathogenesis. Shikata et al. used antibiotics to deplete the gut microbiota in an aneurysm mouse model, and aneurysm induction was drastically reduced due to less macrophage infiltration and cytokine secretion [<xref ref-type="bibr" rid="CR246">246</xref>]. Cerebral cavernous malformation (CCM) is a common type of vascular malformation resulting in hemorrhagic stroke and seizure [<xref ref-type="bibr" rid="CR247">247</xref>]. Tang et al. showed that stimulation of TLR4 by bacteria or LPS accelerates CCM formation, whereas the use of germ-free mice and antibiotics use in mice can prevent CCM. The gut microbiome and endothelial TLR4 act as critical stimulants, suggesting their potential use as novel strategies in CCM therapy [<xref ref-type="bibr" rid="CR248">248</xref>]. Interestingly, Winek et al.’s paradoxical results indicated that a broad-spectrum antibiotic-treated gut microbiota worsens inflammation and stroke in a murine model [<xref ref-type="bibr" rid="CR249">249</xref>]. However, Evangelo Boumis et al. found that consumption of probiotics such as <italic>Lactobacillus rhamnosus</italic> may impose a serious risk of infection in patients with special susceptibility factors, and antibiotic prevention should be considered [<xref ref-type="bibr" rid="CR250">250</xref>]. These findings implied that specific microbiota and antibiotic use result in different outcomes.</p>
</sec>
</sec>
<sec id="Sec19">
<title>Conclusions and perspectives</title>
<p id="Par115">It is now gradually being accepted that the gut microbiota is important in both the maintenance of the intestinal flora and brain physiology. Through the immune system, endocrine system, and bacterial metabolites, the gut microbiota regulates neurotransmission and vascular barriers, which in turn alter host neuropsychological function, cognition, and cerebral vascular physiology. Research and development of potential therapeutic targets are also in progresses. The brain diseases, alteration of gut microbiota, evidenced mechanisms, and potential probiotic-based therapeutics are summarized in Table <xref ref-type="table" rid="Tab2">2</xref>. However, there are still challenges in terms of the experimental design, subjects, models, analytical approach, pipeline, and quality control protocols used in metabolomics studies.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>The brain disorders, alteration of gut microbiota, pathological and molecular signature, and potential probiotic-based therapeutics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Brain disorders</th><th>Dysbiosis of microbiota</th><th>Pathological and molecular signature</th><th>Potential probiotic-based therapeutics</th></tr></thead><tbody><tr><td>Stress and depression</td><td>Increase of <italic>Faecalibacterium, Alistipes, Ruminococcus</italic> [<xref ref-type="bibr" rid="CR112">112</xref>], <italic>Campylobacter jejuni</italic> [<xref ref-type="bibr" rid="CR143">143</xref>] and <italic>Firmicutes</italic>; decrease of <italic>Bacteroidetes</italic> [<xref ref-type="bibr" rid="CR251">251</xref>]</td><td>Activation and releasing of HPA [<xref ref-type="bibr" rid="CR121">121</xref>],VFA [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR141">141</xref>], serotonin 1A receptor [<xref ref-type="bibr" rid="CR122">122</xref>]; reduced expression of BDNF [<xref ref-type="bibr" rid="CR122">122</xref>], GABA receptor [<xref ref-type="bibr" rid="CR119">119</xref>]</td><td><italic>Bifidobacterium infantis</italic> [<xref ref-type="bibr" rid="CR121">121</xref>], <italic>Lactobacillus rhamnosus</italic> [<xref ref-type="bibr" rid="CR119">119</xref>], <italic>Lactobacillus helveticus</italic>, <italic>Bifidobacterium longum</italic> [<xref ref-type="bibr" rid="CR142">142</xref>], and other <italic>Bifidobacterium</italic> strains [<xref ref-type="bibr" rid="CR143">143</xref>]</td></tr><tr><td>Pain and migraine</td><td>Increase of <italic>H.pylor</italic>i [<xref ref-type="bibr" rid="CR162">162</xref>]; dysbiosis [<xref ref-type="bibr" rid="CR163">163</xref>]</td><td>Dysfunction of CB2 and TLR7 [<xref ref-type="bibr" rid="CR160">160</xref>]; inflammatory hypernociception [<xref ref-type="bibr" rid="CR161">161</xref>]; TNF-α induced chronic migrain e[<xref ref-type="bibr" rid="CR163">163</xref>]</td><td><italic>Lactobacillus</italic>, <italic>B. infantis</italic> 35624 and <italic>Lactobacillus farciminis</italic> [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>], <italic>Lactobacillus salivarius</italic> UCC433 1[<xref ref-type="bibr" rid="CR167">167</xref>]</td></tr><tr><td>Autism spectrum disorders</td><td>Decreases of <italic>Faecalibacterium</italic> species [<xref ref-type="bibr" rid="CR150">150</xref>], <italic>Bifidobacteria</italic> species, <italic>Akkermansia muciniphila</italic>; increase of <italic>Lactobacillus</italic>, <italic>Bacteroides, Prevotella</italic>, and <italic>Alistipes</italic> [<xref ref-type="bibr" rid="CR145">145</xref>, <xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]; alteration of <italic>Fusobacteria</italic>, <italic>Verrucomicrobia</italic> and <italic>Firmicutes/Bacteroides</italic> ratio [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td>Disrupted intestinal epithelial permeability [<xref ref-type="bibr" rid="CR114">114</xref>], mucosal inflammation [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>], reduction of SCFA synthesis [<xref ref-type="bibr" rid="CR150">150</xref>], mucosal inflammation [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]</td><td><italic>Bacteroides fragilis</italic> [<xref ref-type="bibr" rid="CR114">114</xref>], <italic>Lactobacillus</italic> species and <italic>Bifidobacterium</italic> species [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR155">155</xref>]</td></tr><tr><td>Parkinson’s disease</td><td>Increase of <italic>H.pylori</italic> [<xref ref-type="bibr" rid="CR174">174</xref>], <italic>E.coli</italic> [<xref ref-type="bibr" rid="CR179">179</xref>], <italic>Ralstonia</italic>, <italic>Oscillospira</italic> and <italic>Bacteroides</italic> [<xref ref-type="bibr" rid="CR180">180</xref>]; decrease of <italic>Prevotellaceae</italic> [<xref ref-type="bibr" rid="CR181">181</xref>], <italic>Blautia</italic>, <italic>Coprococcus</italic>, and <italic>Roseburia</italic> [<xref ref-type="bibr" rid="CR180">180</xref>]</td><td>Higher frequency of α-synuclein detection [<xref ref-type="bibr" rid="CR175">175</xref>], dopaminergic neuronal loss [<xref ref-type="bibr" rid="CR177">177</xref>], bowel inflammation and change of permeability [<xref ref-type="bibr" rid="CR178">178</xref>, <xref ref-type="bibr" rid="CR180">180</xref>]</td><td>Multiple probiotics strains (<italic>Streptococcus salivarius subsp thermophilus, Enterococcus faecium, Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus delbrueckii subsp bulgaricus</italic>, and <italic>Bifidobacterium</italic>) [<xref ref-type="bibr" rid="CR182">182</xref>]</td></tr><tr><td>Alzheimer’s disease</td><td>Chronic <italic>H.pylori</italic> infection [<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR194">194</xref>]; increase of <italic>E.coli</italic>, <italic>Salmonella</italic> spp, <italic>Pseudomonas fluorescens</italic>, <italic>Klebsiella pneumonia</italic>, <italic>Staphylococcus aureus</italic>, <italic>Bacillus subtills</italic>, <italic>Streptomyces coelicolor</italic> [<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR196">196</xref>, <xref ref-type="bibr" rid="CR197">197</xref>]; <italic>Chlamydia pneumoniae</italic> infection [<xref ref-type="bibr" rid="CR199">199</xref>]</td><td>Increased levels of IL-1beta, IL-6, and TNF-alpha [<xref ref-type="bibr" rid="CR186">186</xref>, <xref ref-type="bibr" rid="CR187">187</xref>]; extracellular amyloids such as CsgA, Aβ42, FapC, MccE492, phenol-soluble Modulins, TasA, Chaplins, and β-amyloid exhibit cerebral deposition [<xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR192">192</xref>, <xref ref-type="bibr" rid="CR196">196</xref>, <xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR199">199</xref>]</td><td><italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> [<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR203">203</xref>]; <italic>Lactobacillus fermentum NS9</italic> and <italic>Lactobacillus helveticus NS8</italic> [<xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR202">202</xref>]</td></tr><tr><td>Amyotrophic lateral sclerosis</td><td>Reduced levels of butyrate-producing bacteria, including <italic>Butyrivibrio fibrisolvens</italic>, <italic>Escherichia coli</italic>, <italic>Oscillibacter, Anaerostipes,</italic> and <italic>Lachnospira</italic> [<xref ref-type="bibr" rid="CR213">213</xref>]; increase of glucose-metabolizing <italic>Dorea</italic> [<xref ref-type="bibr" rid="CR214">214</xref>]</td><td>Tetanus and botulinum toxins [<xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]; “leaky gut” [<xref ref-type="bibr" rid="CR212">212</xref>]; higher richness of OTUs [<xref ref-type="bibr" rid="CR215">215</xref>]; reduction of butyrate [<xref ref-type="bibr" rid="CR216">216</xref>]</td><td><italic>Lactobacillus</italic> strains [<xref ref-type="bibr" rid="CR217">217</xref>]</td></tr><tr><td>Multiple sclerosis</td><td>Increase of <italic>Archaea, Psuedomonas, Haemophilus, Blautia</italic>, <italic>Dorea</italic> [<xref ref-type="bibr" rid="CR219">219</xref>], and <italic>Fusobacteria</italic> [<xref ref-type="bibr" rid="CR225">225</xref>]; decrease of <italic>Bacteroidetes phyla, Firmicutes phyla,</italic> [<xref ref-type="bibr" rid="CR218">218</xref>] <italic>Parabacteroides, Adlercreutzia</italic>, <italic>Prevotella</italic> [<xref ref-type="bibr" rid="CR219">219</xref>], <italic>Bacteroides</italic> and <italic>Clostridia</italic> [<xref ref-type="bibr" rid="CR218">218</xref>, <xref ref-type="bibr" rid="CR222">222</xref>]</td><td>BBB integrity disruption and astrocyte pathogenicity [<xref ref-type="bibr" rid="CR222">222</xref>]; increasing proinflammatory cell infiltration and impaired Treg function [<xref ref-type="bibr" rid="CR221">221</xref>]; “leaky gut” [<xref ref-type="bibr" rid="CR219">219</xref>, <xref ref-type="bibr" rid="CR220">220</xref>]</td><td><italic>Bifidobacterium</italic> and lactic acid-producing bacteria [<xref ref-type="bibr" rid="CR223">223</xref>, <xref ref-type="bibr" rid="CR224">224</xref>]; <italic>Bacteroidaceae, Faecalibacterium, Ruminococcus, Lactobacillaceae</italic>, and <italic>Clostridium</italic> [<xref ref-type="bibr" rid="CR226">226</xref>]</td></tr><tr><td>Atherosclerosis</td><td><italic>Lactobacillus rhamnosus</italic> and <italic>Neisseria polysaccharea, Acidovorax</italic> spp. and <italic>H. pylori</italic> cells [<xref ref-type="bibr" rid="CR232">232</xref>]; <italic>Collinsella</italic> [<xref ref-type="bibr" rid="CR233">233</xref>]; <italic>Roseburia</italic> and <italic>Eubacterium</italic> [<xref ref-type="bibr" rid="CR233">233</xref>]</td><td>Carnitine-butyrobetaine-trimethylamine-<italic>N</italic>-oxide pathway [<xref ref-type="bibr" rid="CR235">235</xref>]; cause vascular atherosclerosis by affecting lipid and hormonal homeostasis [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR222">222</xref>]; formation of foam cell by inflammation [<xref ref-type="bibr" rid="CR236">236</xref>, <xref ref-type="bibr" rid="CR237">237</xref>]</td><td><italic>L. acidophilus</italic> 145, <italic>B. longum</italic> 91 3[<xref ref-type="bibr" rid="CR238">238</xref>], <italic>L. acidophilus</italic> and <italic>B. bifidum</italic> [<xref ref-type="bibr" rid="CR239">239</xref>], <italic>L. plantarum ZDY04</italic> against TMAO [<xref ref-type="bibr" rid="CR240">240</xref>]</td></tr><tr><td>Stroke</td><td>Increase of <italic>Porphyromonas gingivalis</italic> [<xref ref-type="bibr" rid="CR242">242</xref>], Gram-negative bacteria [<xref ref-type="bibr" rid="CR243">243</xref>], <italic>Enterobacter</italic>, <italic>Megasphaera</italic>, <italic>Oscillibacter</italic>; decrease of <italic>Bacteroides</italic>, <italic>Prevotella</italic> and <italic>Faecalibacterium</italic> [<xref ref-type="bibr" rid="CR245">245</xref>]</td><td>Formation of blood clots and platelet aggregation [<xref ref-type="bibr" rid="CR244">244</xref>]; decrease of regulatory T cells [<xref ref-type="bibr" rid="CR241">241</xref>]</td><td>Antibiotic administration [<xref ref-type="bibr" rid="CR241">241</xref>]</td></tr><tr><td>Arteriovenous malformation</td><td>Gram-negative bacteria [<xref ref-type="bibr" rid="CR248">248</xref>]</td><td>Macrophage infiltration and cytokine secretion [<xref ref-type="bibr" rid="CR246">246</xref>]; activate TLR4 [<xref ref-type="bibr" rid="CR248">248</xref>]</td><td>Antibiotic and probiotics treatment are controversial [<xref ref-type="bibr" rid="CR248">248</xref>–<xref ref-type="bibr" rid="CR250">250</xref>]</td></tr></tbody></table></table-wrap></p>
<p id="Par116">Thus far, evidence has revealed clear associations between microbiota and host physiology, rather than demonstrating causal relationships. Since there are multiple confounding variables in human fecal experiments, larger sample-size studies are needed for metagenomic biomarker screening. Such studies are more reliable when exposure, demographics, diet, and socioeconomic factors are considered. However, even in population-based metagenomic analyses, the outcome variables are largely influenced by irreducible variables and confounders, while the composition of the microbiome can be explained by limited effects (10–20%) [<xref ref-type="bibr" rid="CR252">252</xref>–<xref ref-type="bibr" rid="CR254">254</xref>]. Another obstacle in current microbiota-based translational medicine is the mild and long-term of effects observed in terms of cognitive or psychological function. It might take months to years of probiotic and microbiota-based therapeutics to influence neuropsychiatric diseases, while the effect of the microbiota on host coagulation can be observed much more rapidly.</p>
<p id="Par117">In addition to human cohort and cross-sectional studies, animal models provide essential evidence to explain how specific microbes affect the host. Animal models, especially murine models, have been widely adopted in pre-clinical experiments to validate the functions of specific microbial species. Early animal studies were established in germ-free animals to reveal associations between host physiology and the effect of the microbiota [<xref ref-type="bibr" rid="CR255">255</xref>]. Specific microorganisms colonizing germ-free animals, probiotic use and fecal microbiota transplantation (FMT) approaches are widely used to elucidate the specific traits and functions of the microbiota. Antibiotic-treated animal models are alternatives for studying the microbial depletion effect on wild-type animals with mature immunity [<xref ref-type="bibr" rid="CR20">20</xref>]. However, there are still many obstacles in the practice of translational medicine using conclusions about the microbiome from animal models, including issues related to genomic background, intestinal differences, dietary habits, and other life exposures. For example, although the human genome shares more than 85% of its genomic sequences with the mouse genome, the expression patterns and protein functions of these species are not exactly the same [<xref ref-type="bibr" rid="CR256">256</xref>–<xref ref-type="bibr" rid="CR259">259</xref>]. In terms of intestinal structure, mice present a relatively larger cecum and small intestine than humans. On the other hand, there are more circular folds (i.e., plicae circularis) in the human small intestine that increase the surface area, whereas the appearance of the mouse mucosa surface is smoother [<xref ref-type="bibr" rid="CR259">259</xref>, <xref ref-type="bibr" rid="CR260">260</xref>]. Life experience is another issue that arises during data analysis, as humans and animals experience different life histories, exercise regimes, circadian cycles, social pressures, and especially food contents. Normally, the diet and chewing in animal experiments are nutritionally controlled and monotonous, while the composition of the human diet varies daily. These diet-related confounders may cause challenges during replication and translation of a model into clinical trials. However, quantitative cohort studies have provided stronger evidence than retrospective questionnaires in human studies, and smaller sample sizes are sometimes adequate to validate a hypothesis [<xref ref-type="bibr" rid="CR244">244</xref>, <xref ref-type="bibr" rid="CR261">261</xref>].</p>
<p id="Par118">The choice of microbiome analysis approaches and their technical stability are additional major challenges. The DNA extraction method, library preparation protocol, sequencer and analytic pipeline employed contribute to the observed biological variation even within a given specimen [<xref ref-type="bibr" rid="CR262">262</xref>]. Recently, large-scale comparative studies identified the importance of sample homogenization, aliquoting and analytical pipelines in data processing [<xref ref-type="bibr" rid="CR263">263</xref>, <xref ref-type="bibr" rid="CR264">264</xref>]. It is also worth noting that the results from 16S and WMS analyses are not fully replicable, since 16S sequencing largely depends on variable region selection, while WMS identifies and quantitates fragments from the entire genome of all organisms in the sample. Therefore, each protocol exhibits a preference for specific taxonomic assignments, which might cause further misinterpretations [<xref ref-type="bibr" rid="CR265">265</xref>–<xref ref-type="bibr" rid="CR268">268</xref>]. Furthermore, most 16S sequencing protocols obtain phylum- or genus-level resolution of taxa, whereas the WMS protocol can provide species or even strain-level information [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR269">269</xref>].</p>
<p id="Par119">Although far from being perfect, the gut microbiota-based therapy is a promising potential approach to be used in future therapies for brain diseases. Doctors and scientists are ready to think outside the pillbox in accord with the suggestion of Hippocrates (400 BC) to “Let food be thy medicine and medicine be thy food” [<xref ref-type="bibr" rid="CR270">270</xref>]. Scientists are also pushing the frontier of the application of the microbiota in the diagnosis, treatment, and prognosis of brain diseases. The robust data produced from MWAS, metabolomics, and multi-omics are hopefully forming a framework that will enable the integration of psychological care, cerebrovascular care, and gastroenterological care into therapies.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>4-EPS</term>
<def>
<p id="Par20">4-ethylphenylsulfate</p>
</def>
</def-item>
<def-item>
<term>AD</term>
<def>
<p id="Par21">Alzheimer’s disease</p>
</def>
</def-item>
<def-item>
<term>AHR</term>
<def>
<p id="Par22">Aryl hydrocarbon receptor</p>
</def>
</def-item>
<def-item>
<term>ALS</term>
<def>
<p id="Par23">Amyotrophic lateral sclerosis</p>
</def>
</def-item>
<def-item>
<term>APP</term>
<def>
<p id="Par24">Aβ precursor protein</p>
</def>
</def-item>
<def-item>
<term>ASDs</term>
<def>
<p id="Par25">Autism spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>AVM</term>
<def>
<p id="Par26">Arteriovenous malformation</p>
</def>
</def-item>
<def-item>
<term>Aβ</term>
<def>
<p id="Par27">Beta-amyloid</p>
</def>
</def-item>
<def-item>
<term>BBB</term>
<def>
<p id="Par28">Blood–brain barrier</p>
</def>
</def-item>
<def-item>
<term>CCM</term>
<def>
<p id="Par29">Cerebral cavernous malformation</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p id="Par30">Central nervous system</p>
</def>
</def-item>
<def-item>
<term>DASH</term>
<def>
<p id="Par31">Dietary approach to stop hypertension</p>
</def>
</def-item>
<def-item>
<term>DMB</term>
<def>
<p id="Par32">3-dimethyl-1-butanol</p>
</def>
</def-item>
<def-item>
<term>EAE</term>
<def>
<p id="Par33">Experimental autoimmune encephalomyelitis</p>
</def>
</def-item>
<def-item>
<term>FISH</term>
<def>
<p id="Par34">Fluorescence in situ hybridization</p>
</def>
</def-item>
<def-item>
<term>FMT</term>
<def>
<p id="Par35">Fecal microbiota transplantation</p>
</def>
</def-item>
<def-item>
<term>GABA</term>
<def>
<p id="Par36">Gamma-aminobutyric acid</p>
</def>
</def-item>
<def-item>
<term>HFD</term>
<def>
<p id="Par37">High-fat diet</p>
</def>
</def-item>
<def-item>
<term>HFHC</term>
<def>
<p id="Par38">High-fat and high-cholesterol diet</p>
</def>
</def-item>
<def-item>
<term>HMP</term>
<def>
<p id="Par39">Human Microbiome Project</p>
</def>
</def-item>
<def-item>
<term>HPA</term>
<def>
<p id="Par40">Hypothalamus-pituitary-adrenal gland axis</p>
</def>
</def-item>
<def-item>
<term>I3S</term>
<def>
<p id="Par41">Indoxyl-3-sulfate</p>
</def>
</def-item>
<def-item>
<term>IAld</term>
<def>
<p id="Par42">Indole-3-aldehyde</p>
</def>
</def-item>
<def-item>
<term>IBD</term>
<def>
<p id="Par43">Inflammatory bowel diseases</p>
</def>
</def-item>
<def-item>
<term>IBS</term>
<def>
<p id="Par44">Irritable bowel syndrome</p>
</def>
</def-item>
<def-item>
<term>ILC3</term>
<def>
<p id="Par45">Group 3 innate lymphoid cells</p>
</def>
</def-item>
<def-item>
<term>IPA</term>
<def>
<p id="Par46">Indole-3-propionic acid</p>
</def>
</def-item>
<def-item>
<term>ITS</term>
<def>
<p id="Par47">Internal transcribed spacer</p>
</def>
</def-item>
<def-item>
<term>LCFAs</term>
<def>
<p id="Par48">Long-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>LPS</term>
<def>
<p id="Par49">Lipopolysaccharides</p>
</def>
</def-item>
<def-item>
<term>LTA</term>
<def>
<p id="Par50">Lipoteichoic acid</p>
</def>
</def-item>
<def-item>
<term>MeDi</term>
<def>
<p id="Par51">Mediterranean diet</p>
</def>
</def-item>
<def-item>
<term>MetaHIT</term>
<def>
<p id="Par52">Metagenomics of the human intestinal tract</p>
</def>
</def-item>
<def-item>
<term>MIND</term>
<def>
<p id="Par53">Mediterranean-DASH Intervention for Neurodegenerative Delay</p>
</def>
</def-item>
<def-item>
<term>MMSE</term>
<def>
<p id="Par54">Mini-mental state examination</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p id="Par55">Magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>MS</term>
<def>
<p id="Par56">Multiple sclerosis</p>
</def>
</def-item>
<def-item>
<term>MWAS</term>
<def>
<p id="Par57">Metagenome-wide association studies</p>
</def>
</def-item>
<def-item>
<term>NGS</term>
<def>
<p id="Par58">Next-generation sequencing</p>
</def>
</def-item>
<def-item>
<term>NMRS</term>
<def>
<p id="Par59">Nuclear magnetic resonance spectroscopy</p>
</def>
</def-item>
<def-item>
<term>NMS</term>
<def>
<p id="Par60">Non-motor symptoms</p>
</def>
</def-item>
<def-item>
<term>PAMPs</term>
<def>
<p id="Par61">Pathogen-associated molecular patterns</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p id="Par62">Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PRRs</term>
<def>
<p id="Par63">Pattern recognition receptors</p>
</def>
</def-item>
<def-item>
<term>rRNA</term>
<def>
<p id="Par64">Ribosomal RNA</p>
</def>
</def-item>
<def-item>
<term>SCFAs</term>
<def>
<p id="Par65">Short-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>SHRSP</term>
<def>
<p id="Par66">Spontaneously hypertensive stroke-prone</p>
</def>
</def-item>
<def-item>
<term>SIBO</term>
<def>
<p id="Par67">Small intestinal bacterial overgrowth</p>
</def>
</def-item>
<def-item>
<term>SSU</term>
<def>
<p id="Par68">Small subunit</p>
</def>
</def-item>
<def-item>
<term>TLR</term>
<def>
<p id="Par69">Toll-like receptor</p>
</def>
</def-item>
<def-item>
<term>TMA</term>
<def>
<p id="Par70">Trimethylamine</p>
</def>
</def-item>
<def-item>
<term>TMAO</term>
<def>
<p id="Par71">Trimethylamine oxide</p>
</def>
</def-item>
<def-item>
<term>TnAse</term>
<def>
<p id="Par72">Tryptophanase</p>
</def>
</def-item>
<def-item>
<term>Tregs</term>
<def>
<p id="Par73">Regulatory T cells</p>
</def>
</def-item>
<def-item>
<term>VFA</term>
<def>
<p id="Par74">Volatile fatty acid</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>Not applicable</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>SBZ, YFJ, and XDC defined the research questions and aims of the study. SBZ, YFJ, KLX, and MC carried out the literature search and selected and interpreted relevant articles. SBZ, YFJ, KLX, MC, WMY, GMZ, and LJ wrote the first draft of the manuscript. SBZ, YFJ, and XDC critically appraised the manuscript, corrected it, and made suggestions for further improvement. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was supported by the National Key Research and Development program of China (grant nos. 2017YFC0907002, 2017YFC0907501), National Nature Science Foundation of China (grant nos. 81502870, 31521003), the International Science and Technology Cooperation Program of China (grant no. 2014DFA32830), the Key Basic Research Grants from Science and Technology Commission of Shanghai Municipality, China (grant no. 16JC1400500), and Shanghai Municipal Science and Technology Major Project (grant no. 2017SHZDZX01).</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par120">Not applicable</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par121">All the authors agree to the publication of this work.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par122">The authors declared no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Madigan</surname>
<given-names>MT</given-names>
</name>
</person-group>
<source/>Brock biology of microorganisms
          <year>2012</year>
<edition>13</edition>
<publisher-loc>San Francisco</publisher-loc>
<publisher-name>Benjamin Cummings</publisher-name>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shulman</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Friedmann</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Theodor Escherich: the first pediatric infectious diseases physician?</article-title>
<source/>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
          <year>2007</year>
<volume>45</volume>
<issue>8</issue>
<fpage>1025</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="doi">10.1086/521946</pub-id>
<pub-id pub-id-type="pmid">17879920</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podolsky</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Metchnikoff and the microbiome</article-title>
<source/>Lancet
          <year>2012</year>
<volume>380</volume>
<issue>9856</issue>
<fpage>1810</fpage>
<lpage>1811</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(12)62018-2</pub-id>
<pub-id pub-id-type="pmid">23189332</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tirosh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Izar</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Prakadan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Wadsworth</surname>
<given-names>MH</given-names>
<suffix>2nd</suffix>
</name>
<name>
<surname>Treacy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Trombetta</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Rotem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<issue>6282</issue>
<fpage>189</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad0501</pub-id>
<pub-id pub-id-type="pmid">27124452</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>TZ</given-names>
</name>
<name>
<surname>Miow</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Miki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Thiery</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients</article-title>
<source/>EMBO molecular medicine
          <year>2014</year>
<volume>6</volume>
<issue>10</issue>
<fpage>1279</fpage>
<lpage>1293</lpage>
<pub-id pub-id-type="doi">10.15252/emmm.201404208</pub-id>
<pub-id pub-id-type="pmid">25214461</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>
<source/>Nature
          <year>2012</year>
<volume>490</volume>
<issue>7418</issue>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nature11450</pub-id>
<pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forslund</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sunagawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prifti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vieira-Silva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gudmundsdottir</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>HK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>
<source/>Nature
          <year>2015</year>
<volume>528</volume>
<issue>7581</issue>
<fpage>262</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1038/nature15766</pub-id>
<pub-id pub-id-type="pmid">26633628</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manichanh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rigottier-Gois</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bonnaud</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gloux</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frangeul</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nalin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jarrin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chardon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Marteau</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach</article-title>
<source/>Gut
          <year>2006</year>
<volume>55</volume>
<issue>2</issue>
<fpage>205</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2005.073817</pub-id>
<pub-id pub-id-type="pmid">16188921</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Ringel-Kulka</surname>
<given-names>T</given-names>
</name>
<collab>Keku TO</collab>
<name>
<surname>Chang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Packey</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Ringel</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome</article-title>
<source/>American journal of physiology Gastrointestinal and liver physiology
          <year>2011</year>
<volume>301</volume>
<issue>5</issue>
<fpage>G799</fpage>
<lpage>G807</lpage>
<pub-id pub-id-type="doi">10.1152/ajpgi.00154.2011</pub-id>
<pub-id pub-id-type="pmid">21737778</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tap</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Sunagawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kultima</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Costea</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Amiot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bohm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Habermann</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Potential of fecal microbiota for early-stage detection of colorectal cancer</article-title>
<source/>Molecular systems biology
          <year>2014</year>
<volume>10</volume>
<fpage>766</fpage>
<pub-id pub-id-type="doi">10.15252/msb.20145645</pub-id>
<pub-id pub-id-type="pmid">25432777</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Francavilla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Giacomo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gobbetti</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders and intestinal microbiota</article-title>
<source/>Gut microbes
          <year>2015</year>
<volume>6</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1080/19490976.2015.1035855</pub-id>
<pub-id pub-id-type="pmid">25835343</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Microbiome disturbances and autism spectrum disorders</article-title>
<source/>Drug metabolism and disposition: the biological fate of chemicals
          <year>2015</year>
<volume>43</volume>
<issue>10</issue>
<fpage>1557</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="doi">10.1124/dmd.115.063826</pub-id>
<pub-id pub-id-type="pmid">25852213</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dirnagl</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Meisel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The Gut Microbiome as Therapeutic target in central nervous system diseases: implications for stroke</article-title>
<source/>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
          <year>2016</year>
<volume>13</volume>
<issue>4</issue>
<fpage>762</fpage>
<lpage>774</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-016-0475-x</pub-id>
<pub-id pub-id-type="pmid">27714645</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Surette</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The interplay between the intestinal microbiota and the brain</article-title>
<source/>Nature reviews Microbiology
          <year>2012</year>
<volume>10</volume>
<issue>11</issue>
<fpage>735</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2876</pub-id>
<pub-id pub-id-type="pmid">23000955</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neunlist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van Landeghem</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mahe</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Derkinderen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Des Varannes</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Rolli-Derkinderen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease</article-title>
<source/>Nature reviews Gastroenterology &amp; Hepatology
          <year>2013</year>
<volume>10</volume>
<issue>2</issue>
<fpage>90</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2012.221</pub-id>
<pub-id pub-id-type="pmid">23165236</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furness</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>The enteric nervous system and neurogastroenterology</article-title>
<source/>Nature Reviews Gastroenterology &amp; Hepatology
          <year>2012</year>
<volume>9</volume>
<issue>5</issue>
<fpage>286</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2012.32</pub-id>
<pub-id pub-id-type="pmid">22392290</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matteoli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boeckxstaens</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>The vagal innervation of the gut and immune homeostasis</article-title>
<source/>Gut
          <year>2013</year>
<volume>62</volume>
<issue>8</issue>
<fpage>1214</fpage>
<lpage>1222</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-302550</pub-id>
<pub-id pub-id-type="pmid">23023166</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>The role of microbiome in central nervous system disorders</article-title>
<source/>Brain, behavior, and immunity
          <year>2014</year>
<volume>38</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2013.12.015</pub-id>
<pub-id pub-id-type="pmid">24370461</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petra</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hatziagelaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation</article-title>
<source/>Clinical therapeutics
          <year>2015</year>
<volume>37</volume>
<issue>5</issue>
<fpage>984</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2015.04.002</pub-id>
<pub-id pub-id-type="pmid">26046241</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vrbanac</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Aksenov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Callewaert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kosciolek</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McCall</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Best practices for analysing microbiomes</article-title>
<source/>Nature reviews Microbiology
          <year>2018</year>
<volume>16</volume>
<issue>7</issue>
<fpage>410</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1038/s41579-018-0029-9</pub-id>
<pub-id pub-id-type="pmid">29795328</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woese</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>Phylogenetic structure of the prokaryotic domain: the primary kingdoms</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>1977</year>
<volume>74</volume>
<issue>11</issue>
<fpage>5088</fpage>
<lpage>5090</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.74.11.5088</pub-id>
<pub-id pub-id-type="pmid">270744</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woese</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Stackebrandt</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Macke</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>A phylogenetic definition of the major eubacterial taxa</article-title>
<source/>Systematic and applied microbiology
          <year>1985</year>
<volume>6</volume>
<fpage>143</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1016/S0723-2020(85)80047-3</pub-id>
<pub-id pub-id-type="pmid">11542017</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Blitchington</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Human colonic biota studied by ribosomal DNA sequence analysis</article-title>
<source/>Appl Environ Microbiol
          <year>1996</year>
<volume>62</volume>
<issue>7</issue>
<fpage>2273</fpage>
<lpage>2278</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.62.7.2273-2278.1996</pub-id>
<pub-id pub-id-type="pmid">8779565</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Garrity</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Tiedje</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy</article-title>
<source/>Appl Environ Microbiol
          <year>2007</year>
<volume>73</volume>
<issue>16</issue>
<fpage>5261</fpage>
<lpage>5267</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.00062-07</pub-id>
<pub-id pub-id-type="pmid">17586664</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<mixed-citation publication-type="other">Hillmann B, Al-Ghalith GA, Shields-Cutler RR, Zhu Q, Gohl DM, Beckman KB, Knight R, Knights D. Evaluating the information content of shallow shotgun metagenomics. mSystems. 2018;3(6).</mixed-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Spakowicz</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Demkowicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Leopold</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Agresta</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis</article-title>
<source/>Nat Commun
          <year>2019</year>
<volume>10</volume>
<issue>1</issue>
<fpage>5029</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-13036-1</pub-id>
<pub-id pub-id-type="pmid">31695033</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breitbart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salamon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andresen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mahaffy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Segall</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mead</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rohwer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Genomic analysis of uncultured marine viral communities</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2002</year>
<volume>99</volume>
<issue>22</issue>
<fpage>14250</fpage>
<lpage>14255</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.202488399</pub-id>
<pub-id pub-id-type="pmid">12384570</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillespie</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Bettermann</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Cianciotto</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Liles</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Rondon</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Clardy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Handelsman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Isolation of antibiotics turbomycin A and B from a metagenomic library of soil microbial DNA</article-title>
<source/>Applied and environmental microbiology
          <year>2002</year>
<volume>68</volume>
<issue>9</issue>
<fpage>4301</fpage>
<lpage>4306</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.68.9.4301-4306.2002</pub-id>
<pub-id pub-id-type="pmid">12200279</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyson</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hugenholtz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Solovyev</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rokhsar</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Banfield</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Community structure and metabolism through reconstruction of microbial genomes from the environment</article-title>
<source/>Nature
          <year>2004</year>
<volume>428</volume>
<issue>6978</issue>
<fpage>37</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1038/nature02340</pub-id>
<pub-id pub-id-type="pmid">14961025</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Metagenome-wide association studies: fine-mining the microbiome</article-title>
<source/>Nature reviews Microbiology
          <year>2016</year>
<volume>14</volume>
<issue>8</issue>
<fpage>508</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2016.83</pub-id>
<pub-id pub-id-type="pmid">27396567</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franzosa</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sirota-Madi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shafquat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abu-Ali</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Huttenhower</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Sequencing and beyond: integrating molecular 'omics' for microbial community profiling</article-title>
<source/>Nature reviews Microbiology
          <year>2015</year>
<volume>13</volume>
<issue>6</issue>
<fpage>360</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro3451</pub-id>
<pub-id pub-id-type="pmid">25915636</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heyer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schallert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zoun</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Becher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Saake</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Benndorf</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Challenges and perspectives of metaproteomic data analysis</article-title>
<source/>Journal of biotechnology
          <year>2017</year>
<volume>261</volume>
<fpage>24</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbiotec.2017.06.1201</pub-id>
<pub-id pub-id-type="pmid">28663049</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics</article-title>
<source/>Circulation Cardiovascular genetics
          <year>2015</year>
<volume>8</volume>
<issue>1</issue>
<fpage>187</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCGENETICS.114.000219</pub-id>
<pub-id pub-id-type="pmid">25691688</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smirnov</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heinzmann</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Forcisi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schmitt-Kopplin</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Challenges of metabolomics in human gut microbiota research</article-title>
<source/>International journal of medical microbiology : IJMM
          <year>2016</year>
<volume>306</volume>
<issue>5</issue>
<fpage>266</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijmm.2016.03.006</pub-id>
<pub-id pub-id-type="pmid">27012595</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrieta</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>The commensal microbiota drives immune homeostasis</article-title>
<source/>Front Immunol
          <year>2012</year>
<volume>3</volume>
<fpage>33</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2012.00033</pub-id>
<pub-id pub-id-type="pmid">22566917</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feillet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The 'hygiene hypothesis' for autoimmune and allergic diseases: an update</article-title>
<source/>Clin Exp Immunol
          <year>2010</year>
<volume>160</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04139.x</pub-id>
<pub-id pub-id-type="pmid">20415844</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Janeway</surname>
<given-names>C</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Innate immune recognition: mechanisms and pathways</article-title>
<source/>Immunological reviews
          <year>2000</year>
<volume>173</volume>
<fpage>89</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1034/j.1600-065X.2000.917309.x</pub-id>
<pub-id pub-id-type="pmid">10719670</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janeway</surname>
<given-names>CA</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Approaching the asymptote? Evolution and revolution in immunology</article-title>
<source/>Cold Spring Harbor symposia on quantitative biology
          <year>1989</year>
<volume>54</volume>
<issue>Pt 1</issue>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1101/SQB.1989.054.01.003</pub-id>
<pub-id pub-id-type="pmid">2700931</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Garcia-Rodenas</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mercenier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Whyte</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Human intestinal barrier function in health and disease</article-title>
<source/>Clinical and translational gastroenterology
          <year>2016</year>
<volume>7</volume>
<issue>10</issue>
<fpage>e196</fpage>
<pub-id pub-id-type="doi">10.1038/ctg.2016.54</pub-id>
<pub-id pub-id-type="pmid">27763627</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wells</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Derrien</surname>
<given-names>M</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Troost</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dekker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meheust</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>WM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homeostasis of the gut barrier and potential biomarkers</article-title>
<source/>American journal of physiology Gastrointestinal and liver physiology
          <year>2017</year>
<volume>312</volume>
<issue>3</issue>
<fpage>G171</fpage>
<lpage>G193</lpage>
<pub-id pub-id-type="doi">10.1152/ajpgi.00048.2015</pub-id>
<pub-id pub-id-type="pmid">27908847</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Deep-brain stimulation for Parkinson's disease</article-title>
<source/>The New England journal of medicine
          <year>2012</year>
<volume>367</volume>
<issue>16</issue>
<fpage>1529</fpage>
<lpage>1538</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMct1208070</pub-id>
<pub-id pub-id-type="pmid">23075179</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rolls</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shechter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>London</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ziv</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ronen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Toll-like receptors modulate adult hippocampal neurogenesis</article-title>
<source/>Nature cell biology
          <year>2007</year>
<volume>9</volume>
<issue>9</issue>
<fpage>1081</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1629</pub-id>
<pub-id pub-id-type="pmid">17704767</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shechter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ronen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rolls</surname>
<given-names>A</given-names>
</name>
<name>
<surname>London</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bakalash</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Toll-like receptor 4 restricts retinal progenitor cell proliferation</article-title>
<source/>The Journal of cell biology
          <year>2008</year>
<volume>183</volume>
<issue>3</issue>
<fpage>393</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200804010</pub-id>
<pub-id pub-id-type="pmid">18981228</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Griffioen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Mughal</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Hutchison</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Lathia</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TLR2 activation inhibits embryonic neural progenitor cell proliferation</article-title>
<source/>Journal of neurochemistry
          <year>2010</year>
<volume>114</volume>
<issue>2</issue>
<fpage>462</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06778.x</pub-id>
<pub-id pub-id-type="pmid">20456021</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keohane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maloney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>YM</given-names>
</name>
</person-group>
<article-title>Tumour necrosis factor-alpha impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: role of Hes1</article-title>
<source/>Molecular and cellular neurosciences
          <year>2010</year>
<volume>43</volume>
<issue>1</issue>
<fpage>127</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2009.10.003</pub-id>
<pub-id pub-id-type="pmid">19840854</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Saada-Madar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Griffioen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mughal</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pita</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Stranahan</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for a developmental role for TLR4 in learning and memory</article-title>
<source/>PloS one
          <year>2012</year>
<volume>7</volume>
<issue>10</issue>
<fpage>e47522</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0047522</pub-id>
<pub-id pub-id-type="pmid">23071817</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Atorvastatin attenuates cognitive deficits and neuroinflammation induced by Abeta1-42 involving modulation of TLR4/TRAF6/NF-kappaB pathway</article-title>
<source/>Journal of molecular neuroscience : MN
          <year>2018</year>
<volume>64</volume>
<issue>3</issue>
<fpage>363</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-018-1032-3</pub-id>
<pub-id pub-id-type="pmid">29417448</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>The microbiota in adaptive immune homeostasis and disease</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<issue>7610</issue>
<fpage>75</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1038/nature18848</pub-id>
<pub-id pub-id-type="pmid">27383982</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Imaoka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuwahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Momose</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohba</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of colonic regulatory T cells by indigenous Clostridium species</article-title>
<source/>Science
          <year>2011</year>
<volume>331</volume>
<issue>6015</issue>
<fpage>337</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1126/science.1198469</pub-id>
<pub-id pub-id-type="pmid">21205640</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Howitt</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Panikov</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gallini</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Bohlooly</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Glickman</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<issue>6145</issue>
<fpage>569</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1126/science.1241165</pub-id>
<pub-id pub-id-type="pmid">23828891</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Tzianabos</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system</article-title>
<source/>Cell
          <year>2005</year>
<volume>122</volume>
<issue>1</issue>
<fpage>107</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2005.05.007</pub-id>
<pub-id pub-id-type="pmid">16009137</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Demengeot</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steinmetz</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses</article-title>
<source/>Nature immunology
          <year>2013</year>
<volume>14</volume>
<issue>4</issue>
<fpage>372</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2552</pub-id>
<pub-id pub-id-type="pmid">23475182</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>II</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tadokoro</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lepelley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lafaille</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Cua</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells</article-title>
<source/>Cell
          <year>2006</year>
<volume>126</volume>
<issue>6</issue>
<fpage>1121</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.07.035</pub-id>
<pub-id pub-id-type="pmid">16990136</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>II</given-names>
</name>
<name>
<surname>Frutos Rde</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Manel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rifkin</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine</article-title>
<source/>Cell host &amp; microbe
          <year>2008</year>
<volume>4</volume>
<issue>4</issue>
<fpage>337</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2008.09.009</pub-id>
<pub-id pub-id-type="pmid">18854238</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishigame</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kakuta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kadoki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nambu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Komiyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fujikado</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tanahashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akitsu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kotaki</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses</article-title>
<source/>Immunity
          <year>2009</year>
<volume>30</volume>
<issue>1</issue>
<fpage>108</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2008.11.009</pub-id>
<pub-id pub-id-type="pmid">19144317</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horai</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zarate-Blades</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Dillenburg-Pilla</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kielczewski</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Jittayasothorn</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Yamane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site</article-title>
<source/>Immunity
          <year>2015</year>
<volume>43</volume>
<issue>2</issue>
<fpage>343</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2015.07.014</pub-id>
<pub-id pub-id-type="pmid">26287682</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mues</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koutrolos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rasbi</surname>
<given-names>ZA</given-names>
</name>
<name>
<surname>Boziki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Johner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wekerle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Krishnamoorthy</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination</article-title>
<source/>Nature
          <year>2011</year>
<volume>479</volume>
<issue>7374</issue>
<fpage>538</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1038/nature10554</pub-id>
<pub-id pub-id-type="pmid">22031325</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGeachy</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tato</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Laurence</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Joyce-Shaikh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blumenschein</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>McClanahan</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>O'Shea</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Cua</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo</article-title>
<source/>Nature immunology
          <year>2009</year>
<volume>10</volume>
<issue>3</issue>
<fpage>314</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1698</pub-id>
<pub-id pub-id-type="pmid">19182808</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coccia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Schiering</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Asquith</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Becher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Powrie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maloy</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells</article-title>
<source/>The Journal of experimental medicine
          <year>2012</year>
<volume>209</volume>
<issue>9</issue>
<fpage>1595</fpage>
<lpage>1609</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20111453</pub-id>
<pub-id pub-id-type="pmid">22891275</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulte-Herbruggen</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Quarcoo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meisel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meisel</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Differential affection of intestinal immune cell populations after cerebral ischemia in mice</article-title>
<source/>Neuroimmunomodulation
          <year>2009</year>
<volume>16</volume>
<issue>3</issue>
<fpage>213</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1159/000205514</pub-id>
<pub-id pub-id-type="pmid">19246945</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz Heijtz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bjorkholm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hibberd</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Forssberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2011</year>
<volume>108</volume>
<issue>7</issue>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obermeier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Daneman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Development, maintenance and disruption of the blood-brain barrier</article-title>
<source/>Nature medicine
          <year>2013</year>
<volume>19</volume>
<issue>12</issue>
<fpage>1584</fpage>
<lpage>1596</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3407</pub-id>
<pub-id pub-id-type="pmid">24309662</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daneman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Prat</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The blood-brain barrier</article-title>
<source/>Cold Spring Harbor perspectives in biology
          <year>2015</year>
<volume>7</volume>
<issue>1</issue>
<fpage>a020412</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a020412</pub-id>
<pub-id pub-id-type="pmid">25561720</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acharya</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Clifford</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tourtellotte</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chamberlain</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pollaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coretti</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Kosciuk</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Nagele</surname>
<given-names>EP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib</article-title>
<source/>Journal of Alzheimer’s disease : JAD
          <year>2013</year>
<volume>35</volume>
<issue>1</issue>
<fpage>179</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-122254</pub-id>
<pub-id pub-id-type="pmid">23388174</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorentino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sapone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Senger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Camhi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kadzielski</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Cascella</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders</article-title>
<source/>Molecular autism
          <year>2016</year>
<volume>7</volume>
<fpage>49</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-016-0110-z</pub-id>
<pub-id pub-id-type="pmid">27957319</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmqvist</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chutna</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bousset</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Aldrin-Kirk</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bjorklund</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Roybon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Melki</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats</article-title>
<source/>Acta neuropathologica
          <year>2014</year>
<volume>128</volume>
<issue>6</issue>
<fpage>805</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-014-1343-6</pub-id>
<pub-id pub-id-type="pmid">25296989</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braniste</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Al-Asmakh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abbaspour</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Korecka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bakocevic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>
<source/>Science translational medicine
          <year>2014</year>
<volume>6</volume>
<issue>263</issue>
<fpage>263ra158</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id>
<pub-id pub-id-type="pmid">25411471</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gelman</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier</article-title>
<source/>Nature medicine
          <year>2003</year>
<volume>9</volume>
<issue>7</issue>
<fpage>900</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="doi">10.1038/nm889</pub-id>
<pub-id pub-id-type="pmid">12808449</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spadoni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fornasa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rescigno</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Organ-specific protection mediated by cooperation between vascular and epithelial barriers</article-title>
<source/>Nature reviews Immunology
          <year>2017</year>
<volume>17</volume>
<issue>12</issue>
<fpage>761</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="doi">10.1038/nri.2017.100</pub-id>
<pub-id pub-id-type="pmid">28869253</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luczynski</surname>
<given-names>Pauline</given-names>
</name>
<name>
<surname>McVey Neufeld</surname>
<given-names>Karen-Anne</given-names>
</name>
<name>
<surname>Oriach</surname>
<given-names>Clara Seira</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>Gerard</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>Timothy G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>John F.</given-names>
</name>
</person-group>
<article-title>Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior</article-title>
<source/>International Journal of Neuropsychopharmacology
          <year>2016</year>
<volume>19</volume>
<issue>8</issue>
<fpage>pyw020</fpage>
<pub-id pub-id-type="doi">10.1093/ijnp/pyw020</pub-id>
<pub-id pub-id-type="pmid">26912607</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>XM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alterations in brain grey matter structures in patients with Crohn's disease and their correlation with psychological distress</article-title>
<source/>Journal of Crohn's &amp; colitis
          <year>2015</year>
<volume>9</volume>
<issue>7</issue>
<fpage>532</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1093/ecco-jcc/jjv057</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mrakotsky</surname>
<given-names>Christine</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>Rajsavi</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>Christopher</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>Catherine</given-names>
</name>
<name>
<surname>Matos</surname>
<given-names>Alana</given-names>
</name>
<name>
<surname>Friel</surname>
<given-names>Shelby</given-names>
</name>
<name>
<surname>Rivkin</surname>
<given-names>Michael</given-names>
</name>
<name>
<surname>Snapper</surname>
<given-names>Scott</given-names>
</name>
</person-group>
<article-title>O-018 New Evidence for Structural Brain Differences in Pediatric Crohnʼs Disease</article-title>
<source/>Inflammatory Bowel Diseases
          <year>2016</year>
<volume>22</volume>
<fpage>S6</fpage>
<lpage>S7</lpage>
<pub-id pub-id-type="doi">10.1097/01.MIB.0000480115.50061.db</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Real</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Serino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Puig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Daunis-i-Estadella</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ricart</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Burcelin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fernandez-Aranda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Portero-Otin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Gut microbiota interacts with brain microstructure and function</article-title>
<source/>The Journal of clinical endocrinology and metabolism
          <year>2015</year>
<volume>100</volume>
<issue>12</issue>
<fpage>4505</fpage>
<lpage>4513</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2015-3076</pub-id>
<pub-id pub-id-type="pmid">26445114</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vipperla</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O'Keefe</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>The microbiota and its metabolites in colonic mucosal health and cancer risk</article-title>
<source/>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
          <year>2012</year>
<volume>27</volume>
<issue>5</issue>
<fpage>624</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1177/0884533612452012</pub-id>
<pub-id pub-id-type="pmid">22868282</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luna</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression</article-title>
<source/>Current opinion in biotechnology
          <year>2015</year>
<volume>32</volume>
<fpage>35</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.copbio.2014.10.007</pub-id>
<pub-id pub-id-type="pmid">25448230</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrensel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ceylan</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>The gut-brain axis: the missing link in depression</article-title>
<source/>Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
          <year>2015</year>
<volume>13</volume>
<issue>3</issue>
<fpage>239</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.9758/cpn.2015.13.3.239</pub-id>
<pub-id pub-id-type="pmid">26598580</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pistollato</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aparicio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Crespo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Manna</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Giampieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Battino</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies</article-title>
<source/>Pharmacological research
          <year>2018</year>
<volume>131</volume>
<fpage>32</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2018.03.012</pub-id>
<pub-id pub-id-type="pmid">29555333</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Barbagallo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Munoz-Garcia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Godos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinez-Gonzalez</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Dietary patterns and cognitive decline: key features for prevention</article-title>
<source/>Current pharmaceutical design
          <year>2019</year>
<volume>25</volume>
<issue>22</issue>
<fpage>2428</fpage>
<lpage>2442</lpage>
<pub-id pub-id-type="doi">10.2174/1381612825666190722110458</pub-id>
<pub-id pub-id-type="pmid">31333085</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tangney</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons</article-title>
<source/>Neurology
          <year>2014</year>
<volume>83</volume>
<issue>16</issue>
<fpage>1410</fpage>
<lpage>1416</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000000884</pub-id>
<pub-id pub-id-type="pmid">25230996</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Taren</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>How poverty affects diet to shape the microbiota and chronic disease</article-title>
<source/>Nature reviews Immunology
          <year>2018</year>
<volume>18</volume>
<issue>4</issue>
<fpage>279</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1038/nri.2017.121</pub-id>
<pub-id pub-id-type="pmid">29109542</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrandt</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sherrill-Mix</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Keilbaugh</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ahima</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Bushman</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
</person-group>
<article-title>High-fat diet determines the composition of the murine gut microbiome independently of obesity</article-title>
<source/>Gastroenterology
          <year>2009</year>
<volume>137</volume>
<issue>5</issue>
<fpage>1716</fpage>
<lpage>1724 e1711-1712</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2009.08.042</pub-id>
<pub-id pub-id-type="pmid">19706296</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Cline</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cardone</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Kibbey</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>GI</given-names>
</name>
</person-group>
<article-title>Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome</article-title>
<source/>Nature
          <year>2016</year>
<volume>534</volume>
<issue>7606</issue>
<fpage>213</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1038/nature18309</pub-id>
<pub-id pub-id-type="pmid">27279214</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ridaura</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice</article-title>
<source/>Sci Transl Med
          <year>2009</year>
<volume>1</volume>
<issue>6</issue>
<fpage>6ra14</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3000322</pub-id>
<pub-id pub-id-type="pmid">20368178</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<mixed-citation publication-type="other">Li Q, Lauber CL, Czarnecki-Maulden G, Pan Y, Hannah SS. Effects of the dietary protein and carbohydrate ratio on gut microbiomes in dogs of different body conditions. MBio. 2017:8(1).</mixed-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bittinger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Keilbaugh</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Bewtra</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knights</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>
<source/>Science
          <year>2011</year>
<volume>334</volume>
<issue>6052</issue>
<fpage>105</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1126/science.1208344</pub-id>
<pub-id pub-id-type="pmid">21885731</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vannini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jeffery</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>La Storia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laghi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Serrazanetti</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Di Cagno</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrocino</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lazzi</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome</article-title>
<source/>Gut
          <year>2016</year>
<volume>65</volume>
<issue>11</issue>
<fpage>1812</fpage>
<lpage>1821</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2015-309957</pub-id>
<pub-id pub-id-type="pmid">26416813</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>LD</given-names>
</name>
</person-group>
<article-title>Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids</article-title>
<source/>Microbiome
          <year>2019</year>
<volume>7</volume>
<issue>1</issue>
<fpage>98</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-019-0713-7</pub-id>
<pub-id pub-id-type="pmid">31255176</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Klipfell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Koeth</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Levison</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Dugar</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Feldstein</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>YM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>
<source/>Nature
          <year>2011</year>
<volume>472</volume>
<issue>7341</issue>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1038/nature09922</pub-id>
<pub-id pub-id-type="pmid">21475195</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koeth</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Levison</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Buffa</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Org</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sheehy</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis</article-title>
<source/>Nature medicine
          <year>2013</year>
<volume>19</volume>
<issue>5</issue>
<fpage>576</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3145</pub-id>
<pub-id pub-id-type="pmid">23563705</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Org</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Buffa</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mehrabian</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbial metabolite TMAO ehances platelet hyperreactivity and thrombosis risk</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<issue>1</issue>
<fpage>111</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.02.011</pub-id>
<pub-id pub-id-type="pmid">26972052</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koren</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Spor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Felin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stombaugh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tremaroli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Behre</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human oral, gut, and plaque microbiota in patients with atherosclerosis</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2011</year>
<volume>108</volume>
<issue>Suppl 1</issue>
<fpage>4592</fpage>
<lpage>4598</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1011383107</pub-id>
<pub-id pub-id-type="pmid">20937873</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Levison</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Koeth</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Britt</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk</article-title>
<source/>The New England journal of medicine
          <year>2013</year>
<volume>368</volume>
<issue>17</issue>
<fpage>1575</fpage>
<lpage>1584</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1109400</pub-id>
<pub-id pub-id-type="pmid">23614584</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Buffa</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Levison</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Org</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zamanian-Daryoush</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Culley</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Non-lethal Inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<issue>7</issue>
<fpage>1585</fpage>
<lpage>1595</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.055</pub-id>
<pub-id pub-id-type="pmid">26687352</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jie</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiome in atherosclerotic cardiovascular disease</article-title>
<source/>Nature communications
          <year>2017</year>
<volume>8</volume>
<issue>1</issue>
<fpage>845</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-00900-1</pub-id>
<pub-id pub-id-type="pmid">29018189</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Vuong</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>QY</given-names>
</name>
<name>
<surname>Nusbaum</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
</person-group>
<article-title>The gut microbiota mediates the anti-seizure effects of the ketogenic diet</article-title>
<source/>Cell
          <year>2018</year>
<volume>173</volume>
<issue>7</issue>
<fpage>1728</fpage>
<lpage>1741 e1713</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.04.027</pub-id>
<pub-id pub-id-type="pmid">29804833</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelder</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stroeve</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Bijlsma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Radonjic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roeselers</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Correlation network analysis reveals relationships between diet-induced changes in human gut microbiota and metabolic health</article-title>
<source/>Nutrition &amp; diabetes
          <year>2014</year>
<volume>4</volume>
<fpage>e122</fpage>
<pub-id pub-id-type="doi">10.1038/nutd.2014.18</pub-id>
<pub-id pub-id-type="pmid">24979151</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways</article-title>
<source/>Biochimica et biophysica acta
          <year>2016</year>
<volume>1862</volume>
<issue>9</issue>
<fpage>1696</fpage>
<lpage>1709</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2016.06.006</pub-id>
<pub-id pub-id-type="pmid">27287254</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourassa</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Alim</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bultman</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ratan</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?</article-title>
<source/>Neuroscience letters
          <year>2016</year>
<volume>625</volume>
<fpage>56</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2016.02.009</pub-id>
<pub-id pub-id-type="pmid">26868600</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topping</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Clifton</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides</article-title>
<source/>Physiological reviews
          <year>2001</year>
<volume>81</volume>
<issue>3</issue>
<fpage>1031</fpage>
<lpage>1064</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.2001.81.3.1031</pub-id>
<pub-id pub-id-type="pmid">11427691</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haghikia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jorg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duscha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manzel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Waschbisch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>May</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wilck</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine</article-title>
<source/>Immunity
          <year>2016</year>
<volume>44</volume>
<issue>4</issue>
<fpage>951</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2016.04.006</pub-id>
<pub-id pub-id-type="pmid">27096322</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schirmer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smeekens</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Vlamakis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jaeger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oosting</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Franzosa</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Ter Horst</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bonder</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking the human gut microbiome to inflammatory cytokine production capacity</article-title>
<source/>Cell
          <year>2016</year>
<volume>167</volume>
<issue>4</issue>
<fpage>1125</fpage>
<lpage>1136 e1128</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.020</pub-id>
<pub-id pub-id-type="pmid">27814509</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duncan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Holtrop</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lobley</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Contribution of acetate to butyrate formation by human faecal bacteria</article-title>
<source/>The British journal of nutrition
          <year>2004</year>
<volume>91</volume>
<issue>6</issue>
<fpage>915</fpage>
<lpage>923</lpage>
<pub-id pub-id-type="doi">10.1079/BJN20041150</pub-id>
<pub-id pub-id-type="pmid">15182395</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Potamitis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thorburn</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Macia</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The role of short-chain fatty acids in health and disease</article-title>
<source/>Advances in immunology
          <year>2014</year>
<volume>121</volume>
<fpage>91</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-12-800100-4.00003-9</pub-id>
<pub-id pub-id-type="pmid">24388214</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Regulation of short-chain fatty acid production</article-title>
<source/>The Proceedings of the Nutrition Society
          <year>2003</year>
<volume>62</volume>
<issue>1</issue>
<fpage>67</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1079/PNS2002207</pub-id>
<pub-id pub-id-type="pmid">12740060</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maslowski</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kranich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sierro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schilter</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Rolph</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Artis</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</article-title>
<source/>Nature
          <year>2009</year>
<volume>461</volume>
<issue>7268</issue>
<fpage>1282</fpage>
<lpage>1286</lpage>
<pub-id pub-id-type="doi">10.1038/nature08530</pub-id>
<pub-id pub-id-type="pmid">19865172</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasubuchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ichimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<issue>4</issue>
<fpage>2839</fpage>
<lpage>2849</lpage>
<pub-id pub-id-type="doi">10.3390/nu7042839</pub-id>
<pub-id pub-id-type="pmid">25875123</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krautkramer</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kreznar</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Vivas</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Barrett-Wilt</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Rabaglia</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Attie</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Denu</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues</article-title>
<source/>Molecular cell
          <year>2016</year>
<volume>64</volume>
<issue>5</issue>
<fpage>982</fpage>
<lpage>992</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2016.10.025</pub-id>
<pub-id pub-id-type="pmid">27889451</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Borucki</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Tjon</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Ardura-Fabregat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Lima</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Gutierrez-Vazquez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hewson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Staszewski</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglial control of astrocytes in response to microbial metabolites</article-title>
<source/>Nature
          <year>2018</year>
<volume>557</volume>
<issue>7707</issue>
<fpage>724</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0119-x</pub-id>
<pub-id pub-id-type="pmid">29769726</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mascanfroni</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Bunse</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kenison</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blain</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor</article-title>
<source/>Nature medicine
          <year>2016</year>
<volume>22</volume>
<issue>6</issue>
<fpage>586</fpage>
<lpage>597</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4106</pub-id>
<pub-id pub-id-type="pmid">27158906</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeder</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Dinatale</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Flaveny</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Laurenzana</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Strom</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Omiecinski</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor</article-title>
<source/>Biochemistry
          <year>2010</year>
<volume>49</volume>
<issue>2</issue>
<fpage>393</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1021/bi901786x</pub-id>
<pub-id pub-id-type="pmid">20000589</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaglin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rhimi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pons</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goustard</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dauge</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Maguin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Naudon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rabot</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Indole, a signaling molecule droduced by the gut microbiota, negatively impacts emotional behaviors in rats</article-title>
<source/>Frontiers in neuroscience
          <year>2018</year>
<volume>12</volume>
<fpage>216</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2018.00216</pub-id>
<pub-id pub-id-type="pmid">29686603</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szczesniak</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hestad</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Rudi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Isovaleric acid in stool correlates with human depression</article-title>
<source/>Nutritional neuroscience
          <year>2016</year>
<volume>19</volume>
<issue>7</issue>
<fpage>279</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1179/1476830515Y.0000000007</pub-id>
<pub-id pub-id-type="pmid">25710209</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Compher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>EZ</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Bittinger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chehoud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Albenberg</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Nessel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gilroy</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production</article-title>
<source/>Gut
          <year>2016</year>
<volume>65</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2014-308209</pub-id>
<pub-id pub-id-type="pmid">25431456</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hsien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Codelli</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reisman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>7</issue>
<fpage>1451</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miles</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hines</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals</article-title>
<source/>Hormones and behavior
          <year>2006</year>
<volume>50</volume>
<issue>5</issue>
<fpage>708</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2006.06.008</pub-id>
<pub-id pub-id-type="pmid">16884726</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keefer</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Behavioural medicine and gastrointestinal disorders: the promise of positive psychology</article-title>
<source/>Nature reviews Gastroenterology &amp; hepatology
          <year>2018</year>
<volume>15</volume>
<issue>6</issue>
<fpage>378</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1038/s41575-018-0001-1</pub-id>
<pub-id pub-id-type="pmid">29651112</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grenham</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scully</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Moloney</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>
<source/>Molecular psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>6</issue>
<fpage>666</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.77</pub-id>
<pub-id pub-id-type="pmid">22688187</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messaoudi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lalonde</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Violle</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Javelot</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Desor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nejdi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bisson</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Rougeot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pichelin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cazaubiel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects</article-title>
<source/>The British journal of nutrition
          <year>2011</year>
<volume>105</volume>
<issue>5</issue>
<fpage>755</fpage>
<lpage>764</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114510004319</pub-id>
<pub-id pub-id-type="pmid">20974015</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Escaravage</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Savignac</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2011</year>
<volume>108</volume>
<issue>38</issue>
<fpage>16050</fpage>
<lpage>16055</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id>
<pub-id pub-id-type="pmid">21876150</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janik</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thomason</surname>
<given-names>LAM</given-names>
</name>
<name>
<surname>Stanisz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stanisz</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate</article-title>
<source/>NeuroImage
          <year>2016</year>
<volume>125</volume>
<fpage>988</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.11.018</pub-id>
<pub-id pub-id-type="pmid">26577887</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>XN</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koga</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>
<source/>The Journal of physiology
          <year>2004</year>
<volume>558</volume>
<issue>Pt 1</issue>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neufeld</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Reduced anxiety-like behavior and central neurochemical change in germ-free mice</article-title>
<source/>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
          <year>2011</year>
<volume>23</volume>
<issue>3</issue>
<fpage>255</fpage>
<lpage>264, e119</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01620.x</pub-id>
<pub-id pub-id-type="pmid">21054680</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Verdu</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Malinowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Blennerhassett</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>KA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice</article-title>
<source/>Gastroenterology
          <year>2010</year>
<volume>139</volume>
<issue>6</issue>
<fpage>2102</fpage>
<lpage>2112 e2101</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2010.06.063</pub-id>
<pub-id pub-id-type="pmid">20600016</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Denou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Blennerhassett</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice</article-title>
<source/>Gastroenterology
          <year>2011</year>
<volume>141</volume>
<issue>2</issue>
<fpage>599</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.052</pub-id>
<pub-id pub-id-type="pmid">21683077</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crumeyrolle-Arias</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaglin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bruneau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vancassel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cardona</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dauge</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Naudon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rabot</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats</article-title>
<source/>Psychoneuroendocrinology
          <year>2014</year>
<volume>42</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.014</pub-id>
<pub-id pub-id-type="pmid">24636517</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desbonnet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Microbiota is essential for social development in the mouse</article-title>
<source/>Molecular psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.65</pub-id>
<pub-id pub-id-type="pmid">23689536</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degroote</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hunting</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Takser</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Maternal gut and fetal brain connection: increased anxiety and reduced social interactions in Wistar rat offspring following peri-conceptional antibiotic exposure</article-title>
<source/>Progress in neuro-psychopharmacology &amp; biological psychiatry
          <year>2016</year>
<volume>71</volume>
<fpage>76</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2016.06.010</pub-id>
<pub-id pub-id-type="pmid">27346743</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frohlich</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Farzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mayerhofer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reichmann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jacan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zinser</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bordag</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Magnes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frohlich</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication</article-title>
<source/>Brain, behavior, and immunity
          <year>2016</year>
<volume>56</volume>
<fpage>140</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.02.020</pub-id>
<pub-id pub-id-type="pmid">26923630</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gareau</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Wine</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Whary</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Philpott</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Macqueen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Bacterial infection causes stress-induced memory dysfunction in mice</article-title>
<source/>Gut
          <year>2011</year>
<volume>60</volume>
<issue>3</issue>
<fpage>307</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2009.202515</pub-id>
<pub-id pub-id-type="pmid">20966022</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mattei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heimesaat</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Bereswill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alutis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>French</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hambardzumyan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matzinger</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dunay</surname>
<given-names>IR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis</article-title>
<source/>Cell reports
          <year>2016</year>
<volume>15</volume>
<issue>9</issue>
<fpage>1945</fpage>
<lpage>1956</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.074</pub-id>
<pub-id pub-id-type="pmid">27210745</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gaykema</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Goehler</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium</article-title>
<source/>Physiology &amp; behavior
          <year>2006</year>
<volume>89</volume>
<issue>3</issue>
<fpage>350</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2006.06.019</pub-id>
<pub-id pub-id-type="pmid">16887154</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jansson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Field</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fierer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fuhrman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hugenholtz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van der Lelie</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unlocking the potential of metagenomics through replicated experimental design</article-title>
<source/>Nature biotechnology
          <year>2012</year>
<volume>30</volume>
<issue>6</issue>
<fpage>513</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.2235</pub-id>
<pub-id pub-id-type="pmid">22678395</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Dominguez-Bello</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>The human microbiome before birth</article-title>
<source/>Cell host &amp; microbe
          <year>2016</year>
<volume>20</volume>
<issue>5</issue>
<fpage>558</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2016.10.014</pub-id>
<pub-id pub-id-type="pmid">27832586</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostic</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Siljander</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vatanen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hyotylainen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hamalainen</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Peet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tillmann</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Poho</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mattila</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes</article-title>
<source/>Cell host &amp; microbe
          <year>2015</year>
<volume>17</volume>
<issue>2</issue>
<fpage>260</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2015.01.001</pub-id>
<pub-id pub-id-type="pmid">25662751</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Sholar</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Bilbo</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Microglia and memory: modulation by early-life infection</article-title>
<source/>The Journal of neuroscience : the official journal of the Society for Neuroscience
          <year>2011</year>
<volume>31</volume>
<issue>43</issue>
<fpage>15511</fpage>
<lpage>15521</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3688-11.2011</pub-id>
<pub-id pub-id-type="pmid">22031897</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dinel</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Laye</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Castanon</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation</article-title>
<source/>Brain, behavior, and immunity
          <year>2014</year>
<volume>41</volume>
<fpage>10</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2014.03.012</pub-id>
<pub-id pub-id-type="pmid">24681251</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magnusson</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Hauck</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jeffrey</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Humphrey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bermudez</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Relationships between diet-related changes in the gut microbiome and cognitive flexibility</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>300</volume>
<fpage>128</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.016</pub-id>
<pub-id pub-id-type="pmid">25982560</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Mahony</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Scully</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Codling</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ceolho</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses</article-title>
<source/>Biological psychiatry
          <year>2009</year>
<volume>65</volume>
<issue>3</issue>
<fpage>263</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2008.06.026</pub-id>
<pub-id pub-id-type="pmid">18723164</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bangsgaard Bendtsen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Krych</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Josefsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse</article-title>
<source/>PloS one
          <year>2012</year>
<volume>7</volume>
<issue>10</issue>
<fpage>e46231</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0046231</pub-id>
<pub-id pub-id-type="pmid">23056268</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sarkhel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dhali</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>Anxiety and depression in irritable bowel syndrome</article-title>
<source/>Indian journal of psychological medicine
          <year>2017</year>
<volume>39</volume>
<issue>6</issue>
<fpage>741</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="doi">10.4103/IJPSYM.IJPSYM_46_17</pub-id>
<pub-id pub-id-type="pmid">29284804</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herbert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>PO</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Croudace</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Goodyer</surname>
<given-names>IM</given-names>
</name>
</person-group>
<article-title>Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2014</year>
<volume>111</volume>
<issue>9</issue>
<fpage>3638</fpage>
<lpage>3643</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1318786111</pub-id>
<pub-id pub-id-type="pmid">24550453</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait-Belgnaoui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Braniste</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ramalho</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marrot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Houdeau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice</article-title>
<source/>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
          <year>2014</year>
<volume>26</volume>
<issue>4</issue>
<fpage>510</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1111/nmo.12295</pub-id>
<pub-id pub-id-type="pmid">24372793</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Theije</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Wopereis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ramadan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Eijndthoven</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Knol</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garssen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kraneveld</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Oozeer</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Altered gut microbiota and activity in a murine model of autism spectrum disorders</article-title>
<source/>Brain, behavior, and immunity
          <year>2014</year>
<volume>37</volume>
<fpage>197</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2013.12.005</pub-id>
<pub-id pub-id-type="pmid">24333160</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curran</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Behaviors associated with fever in children with autism spectrum disorders</article-title>
<source/>Pediatrics
          <year>2007</year>
<volume>120</volume>
<issue>6</issue>
<fpage>e1386</fpage>
<lpage>e1392</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-0360</pub-id>
<pub-id pub-id-type="pmid">18055656</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandler</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Maxwell</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Vaisanen</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Wexler</surname>
<given-names>HM</given-names>
</name>
</person-group>
<article-title>Short-term benefit from oral vancomycin treatment of regressive-onset autism</article-title>
<source/>Journal of child neurology
          <year>2000</year>
<volume>15</volume>
<issue>7</issue>
<fpage>429</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1177/088307380001500701</pub-id>
<pub-id pub-id-type="pmid">10921511</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Critchfield</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>van Hemert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ash</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The potential role of probiotics in the management of childhood autism spectrum disorders</article-title>
<source/>Gastroenterology research and practice
          <year>2011</year>
<volume>2011</volume>
<fpage>161358</fpage>
<pub-id pub-id-type="doi">10.1155/2011/161358</pub-id>
<pub-id pub-id-type="pmid">22114588</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klukowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wasilewska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lebensztejn</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Sleep and gastrointestinal disturbances in autism spectrum disorder in children</article-title>
<source/>Developmental period medicine
          <year>2015</year>
<volume>19</volume>
<issue>2</issue>
<fpage>157</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="pmid">26384115</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaidez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Gastrointestinal problems in children with autism, developmental delays or typical development</article-title>
<source/>Journal of autism and developmental disorders
          <year>2014</year>
<volume>44</volume>
<issue>5</issue>
<fpage>1117</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-013-1973-x</pub-id>
<pub-id pub-id-type="pmid">24193577</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Perman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Autistic disorder and gastrointestinal disease</article-title>
<source/>Current opinion in pediatrics
          <year>2002</year>
<volume>14</volume>
<issue>5</issue>
<fpage>583</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1097/00008480-200210000-00004</pub-id>
<pub-id pub-id-type="pmid">12352252</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vannini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Siragusa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Giacomo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Serrazzanetti</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Cristofori</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guerzoni</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gobbetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Francavilla</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified</article-title>
<source/>PloS one
          <year>2013</year>
<volume>8</volume>
<issue>10</issue>
<fpage>e76993</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0076993</pub-id>
<pub-id pub-id-type="pmid">24130822</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Quig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity</article-title>
<source/>BMC gastroenterology
          <year>2011</year>
<volume>11</volume>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1471-230X-11-22</pub-id>
<pub-id pub-id-type="pmid">21410934</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christophersen</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Sorich</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Angley</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism</article-title>
<source/>Applied and environmental microbiology
          <year>2011</year>
<volume>77</volume>
<issue>18</issue>
<fpage>6718</fpage>
<lpage>6721</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.05212-11</pub-id>
<pub-id pub-id-type="pmid">21784919</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Dowd</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Gontcharova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Henley</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Wolcott</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Summanen</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Granpeesheh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>
<source/>Anaerobe
          <year>2010</year>
<volume>16</volume>
<issue>4</issue>
<fpage>444</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.06.008</pub-id>
<pub-id pub-id-type="pmid">20603222</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parracho</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>McCartney</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children</article-title>
<source/>Journal of medical microbiology
          <year>2005</year>
<volume>54</volume>
<issue>Pt 10</issue>
<fpage>987</fpage>
<lpage>991</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.46101-0</pub-id>
<pub-id pub-id-type="pmid">16157555</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saulnier</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ringel</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Heyman</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bercik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Verdu</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intestinal microbiome, probiotics and prebiotics in neurogastroenterology</article-title>
<source/>Gut microbes
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.4161/gmic.22973</pub-id>
<pub-id pub-id-type="pmid">23202796</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theodorou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ait Belgnaoui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Agostini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eutamene</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome</article-title>
<source/>Gut microbes
          <year>2014</year>
<volume>5</volume>
<issue>3</issue>
<fpage>430</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="doi">10.4161/gmic.29796</pub-id>
<pub-id pub-id-type="pmid">25184834</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachdev</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance</article-title>
<source/>Therapeutic advances in chronic disease
          <year>2013</year>
<volume>4</volume>
<issue>5</issue>
<fpage>223</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1177/2040622313496126</pub-id>
<pub-id pub-id-type="pmid">23997926</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraji</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zarinfar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zanjani</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Morteza</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial</article-title>
<source/>Pain physician
          <year>2012</year>
<volume>15</volume>
<issue>6</issue>
<fpage>495</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">23159967</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smilowicz</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>An osteopathic approach to gastrointestinal disease: somatic clues for diagnosis and clinical challenges associated with Helicobacter pylori antibiotic resistance</article-title>
<source/>The Journal of the American Osteopathic Association
          <year>2013</year>
<volume>113</volume>
<issue>5</issue>
<fpage>404</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">23667194</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cerda-Cuellar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice</article-title>
<source/>Gut microbes
          <year>2015</year>
<volume>6</volume>
<issue>1</issue>
<fpage>10</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.4161/19490976.2014.990790</pub-id>
<pub-id pub-id-type="pmid">25531553</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Fagundes</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Cisalpino</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>FQ</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Nicoli</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Commensal microbiota is fundamental for the development of inflammatory pain</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2008</year>
<volume>105</volume>
<issue>6</issue>
<fpage>2193</fpage>
<lpage>2197</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0711891105</pub-id>
<pub-id pub-id-type="pmid">18268332</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>GX</given-names>
</name>
</person-group>
<article-title>Association between Helicobacter pylori infection and migraine: a meta-analysis</article-title>
<source/>World journal of gastroenterology
          <year>2014</year>
<volume>20</volume>
<issue>40</issue>
<fpage>14965</fpage>
<lpage>14972</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i40.14965</pub-id>
<pub-id pub-id-type="pmid">25356058</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<mixed-citation publication-type="other">Tang Y, Liu S, Shu H, Yanagisawa L, Tao F. Gut microbiota dysbiosis enhances migraine-like pain via TNFalpha upregulation. Molecular neurobiology. 2019.</mixed-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rousseaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thuru</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gelot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barnich</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Neut</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dubuquoy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dubuquoy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Merour</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Geboes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chamaillard</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors</article-title>
<source/>Nature medicine
          <year>2007</year>
<volume>13</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1038/nm1521</pub-id>
<pub-id pub-id-type="pmid">17159985</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKernan</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat</article-title>
<source/>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
          <year>2010</year>
<volume>22</volume>
<issue>9</issue>
<fpage>1029</fpage>
<lpage>1035, e1268</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01520.x</pub-id>
<pub-id pub-id-type="pmid">20518856</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait-Belgnaoui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eutamene</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Houdeau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bueno</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fioramonti</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats</article-title>
<source/>Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
          <year>2009</year>
<volume>21</volume>
<issue>5</issue>
<fpage>567</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2982.2009.01280.x</pub-id>
<pub-id pub-id-type="pmid">19309441</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Mahony</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O'Sullivan</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kiely</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles</article-title>
<source/>Gastroenterology
          <year>2005</year>
<volume>128</volume>
<issue>3</issue>
<fpage>541</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2004.11.050</pub-id>
<pub-id pub-id-type="pmid">15765388</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellegrini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Antonioli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Colucci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blandizzi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fornai</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?</article-title>
<source/>Acta neuropathologica
          <year>2018</year>
<volume>136</volume>
<issue>3</issue>
<fpage>345</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-018-1856-5</pub-id>
<pub-id pub-id-type="pmid">29797112</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spielman</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Klegeris</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases</article-title>
<source/>Neurochemistry international
          <year>2018</year>
<volume>120</volume>
<fpage>149</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2018.08.005</pub-id>
<pub-id pub-id-type="pmid">30114473</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilvis</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Kahonen-Vare</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Jolkkonen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valvanne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pitkala</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Strandberg</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Predictors of cognitive decline and mortality of aged people over a 10-year period</article-title>
<source/>The journals of gerontology Series A, Biological sciences and medical sciences
          <year>2004</year>
<volume>59</volume>
<issue>3</issue>
<fpage>268</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/59.3.M268</pub-id>
<pub-id pub-id-type="pmid">15031312</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serres</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Broom</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Tyler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>van Kasteren</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Sibson</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Systemic inflammatory response reactivates immune-mediated lesions in rat brain</article-title>
<source/>The Journal of neuroscience : the official journal of the Society for Neuroscience
          <year>2009</year>
<volume>29</volume>
<issue>15</issue>
<fpage>4820</fpage>
<lpage>4828</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0406-09.2009</pub-id>
<pub-id pub-id-type="pmid">19369550</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reeve</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Simcox</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Ageing and Parkinson's disease: why is advancing age the biggest risk factor?</article-title>
<source/>Ageing research reviews
          <year>2014</year>
<volume>14</volume>
<fpage>19</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.arr.2014.01.004</pub-id>
<pub-id pub-id-type="pmid">24503004</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felice</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>O'Keeffe</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>O'Mahony</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Microbiota-gut-brain signalling in Parkinson's disease: implications for non-motor symptoms</article-title>
<source/>Parkinsonism &amp; related disorders
          <year>2016</year>
<volume>27</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2016.03.012</pub-id>
<pub-id pub-id-type="pmid">27013171</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Visanji</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Gastrointestinal dysfunction in Parkinson's disease</article-title>
<source/>The Lancet Neurology
          <year>2015</year>
<volume>14</volume>
<issue>6</issue>
<fpage>625</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(15)00007-1</pub-id>
<pub-id pub-id-type="pmid">25987282</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Altered gut microbiome and intestinal pathology in Parkinson's disease</article-title>
<source/>Journal of movement disorders
          <year>2019</year>
<volume>12</volume>
<issue>2</issue>
<fpage>67</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.14802/jmd.18067</pub-id>
<pub-id pub-id-type="pmid">31158941</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulusoy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Helwig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Klinkenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Powley</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Di Monte</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Brain-to-stomach transfer of alpha-synuclein via vagal preganglionic projections</article-title>
<source/>Acta neuropathologica
          <year>2017</year>
<volume>133</volume>
<issue>3</issue>
<fpage>381</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-016-1661-y</pub-id>
<pub-id pub-id-type="pmid">28012041</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villaran</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Espinosa-Oliva</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sarmiento</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Pablos</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Arguelles</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Delgado-Cortes</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Sobrino</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Van Rooijen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Venero</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Herrera</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease</article-title>
<source/>Journal of neurochemistry
          <year>2010</year>
<volume>114</volume>
<issue>6</issue>
<fpage>1687</fpage>
<lpage>1700</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06879.x</pub-id>
<pub-id pub-id-type="pmid">20584104</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Kordower</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaglin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Dodiya</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease</article-title>
<source/>PloS one
          <year>2011</year>
<volume>6</volume>
<issue>12</issue>
<fpage>e28032</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0028032</pub-id>
<pub-id pub-id-type="pmid">22145021</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salat-Foix</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ranawaya</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meddings</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suchowersky</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Increased intestinal permeability and Parkinson disease patients: chicken or egg?</article-title>
<source/>The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques
          <year>2012</year>
<volume>39</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1017/S0317167100013202</pub-id>
<pub-id pub-id-type="pmid">22343151</pub-id>
</element-citation>
</ref>
<ref id="CR180">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Engen</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Naqib</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Forsyth</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mutlu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Colonic bacterial composition in Parkinson's disease</article-title>
<source/>Movement disorders : official journal of the Movement Disorder Society
          <year>2015</year>
<volume>30</volume>
<issue>10</issue>
<fpage>1351</fpage>
<lpage>1360</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26307</pub-id>
<pub-id pub-id-type="pmid">26179554</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheperjans</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aho</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Koskinen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Paulin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pekkonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Haapaniemi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kaakkola</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eerola-Rautio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pohja</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota are related to Parkinson's disease and clinical phenotype</article-title>
<source/>Movement disorders : official journal of the Movement Disorder Society
          <year>2015</year>
<volume>30</volume>
<issue>3</issue>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26069</pub-id>
<pub-id pub-id-type="pmid">25476529</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barichella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pacchetti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bolliri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cassani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Iorio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pusani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pinelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Privitera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cesari</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Faierman</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT</article-title>
<source/>Neurology
          <year>2016</year>
<volume>87</volume>
<issue>12</issue>
<fpage>1274</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000003127</pub-id>
<pub-id pub-id-type="pmid">27543643</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peter</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dubinsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bressman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease</article-title>
<source/>JAMA neurology
          <year>2018</year>
<volume>75</volume>
<issue>8</issue>
<fpage>939</fpage>
<lpage>946</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2018.0605</pub-id>
<pub-id pub-id-type="pmid">29710331</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camacho-Soto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Searles Nielsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Racette</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries</article-title>
<source/>Parkinsonism &amp; related disorders
          <year>2018</year>
<volume>50</volume>
<fpage>23</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2018.02.008</pub-id>
<pub-id pub-id-type="pmid">29459115</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzheimer's</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>2016 Alzheimer's disease facts and figures</article-title>
<source/>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
          <year>2016</year>
<volume>12</volume>
<issue>4</issue>
<fpage>459</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2016.03.001</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Innate immune activation in Alzheimer's disease</article-title>
<source/>Annals of translational medicine
          <year>2018</year>
<volume>6</volume>
<issue>10</issue>
<fpage>177</fpage>
<pub-id pub-id-type="doi">10.21037/atm.2018.04.20</pub-id>
<pub-id pub-id-type="pmid">29951499</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagyinszky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Giau</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Suk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>An</surname>
<given-names>SSA</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis</article-title>
<source/>Journal of the neurological sciences
          <year>2017</year>
<volume>376</volume>
<fpage>242</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2017.03.031</pub-id>
<pub-id pub-id-type="pmid">28431620</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gioglio</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?</article-title>
<source/>Journal of Alzheimer's disease : JAD
          <year>2014</year>
<volume>39</volume>
<issue>1</issue>
<fpage>169</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-131394</pub-id>
<pub-id pub-id-type="pmid">24150108</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>HB</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease: assessing the role of Spirochetes, biofilms, the immune system, and amyloid-beta with regard to potential treatment and prevention</article-title>
<source/>Journal of Alzheimer's disease : JAD
          <year>2016</year>
<volume>53</volume>
<issue>4</issue>
<fpage>1271</fpage>
<lpage>1276</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-160388</pub-id>
<pub-id pub-id-type="pmid">27372648</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>BR</given-names>
</name>
</person-group>
<article-title>Microbial amyloids--functions and interactions within the host</article-title>
<source/>Current opinion in microbiology
          <year>2013</year>
<volume>16</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2012.12.001</pub-id>
<pub-id pub-id-type="pmid">23313395</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Brannstrom</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Almqvist</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms</article-title>
<source/>The Journal of biological chemistry
          <year>2012</year>
<volume>287</volume>
<issue>42</issue>
<fpage>35092</fpage>
<lpage>35103</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.383737</pub-id>
<pub-id pub-id-type="pmid">22891247</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Microbial-generated amyloids and Alzheimer's disease (AD)</article-title>
<source/>Frontiers in aging neuroscience
          <year>2015</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2015.00009</pub-id>
<pub-id pub-id-type="pmid">25713531</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roubaud-Baudron</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krolak-Salmon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Quadrio</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Megraud</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salles</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results</article-title>
<source/>Neurobiology of aging
          <year>2012</year>
<volume>33</volume>
<issue>5</issue>
<fpage>1009 e1011</fpage>
<lpage>1009 e1009</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.10.021</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bu</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>HY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A study on the association between infectious burden and Alzheimer's disease</article-title>
<source/>European journal of neurology
          <year>2015</year>
<volume>22</volume>
<issue>12</issue>
<fpage>1519</fpage>
<lpage>1525</lpage>
<pub-id pub-id-type="doi">10.1111/ene.12477</pub-id>
<pub-id pub-id-type="pmid">24910016</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Tuo</surname>
<given-names>QZ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3beta</article-title>
<source/>JAD
          <year>2015</year>
<volume>43</volume>
<issue>1</issue>
<fpage>153</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-140198</pub-id>
<pub-id pub-id-type="pmid">25079798</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedland</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>The role of microbial amyloid in neurodegeneration</article-title>
<source/>PLoS pathogens
          <year>2017</year>
<volume>13</volume>
<issue>12</issue>
<fpage>e1006654</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1006654</pub-id>
<pub-id pub-id-type="pmid">29267402</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Rickard</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>BR</given-names>
</name>
</person-group>
<article-title>Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms</article-title>
<source/>PLoS pathogens
          <year>2012</year>
<volume>8</volume>
<issue>6</issue>
<fpage>e1002744</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1002744</pub-id>
<pub-id pub-id-type="pmid">22685403</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harach</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Marungruang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Duthilleul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cheatham</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mc Coy</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Frisoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Fak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jucker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lasser</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota</article-title>
<source/>Scientific reports
          <year>2017</year>
<volume>7</volume>
<fpage>41802</fpage>
<pub-id pub-id-type="doi">10.1038/srep41802</pub-id>
<pub-id pub-id-type="pmid">28176819</pub-id>
</element-citation>
</ref>
<ref id="CR199">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Atrache</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Hingley</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Appelt</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of beta-amyloid found in Alzheimer disease</article-title>
<source/>BMC neuroscience
          <year>2019</year>
<volume>20</volume>
<issue>1</issue>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/s12868-019-0489-5</pub-id>
<pub-id pub-id-type="pmid">30786875</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athari Nik Azm</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Djazayeri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Safa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Azami</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ahmadvand</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sabbaghziarani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sharifzadeh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vafa</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in beta-amyloid (1-42) injected rats</article-title>
<source/>Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
          <year>2018</year>
<volume>43</volume>
<issue>7</issue>
<fpage>718</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1139/apnm-2017-0648</pub-id>
<pub-id pub-id-type="pmid">29462572</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats</article-title>
<source/>Beneficial microbes
          <year>2015</year>
<volume>6</volume>
<issue>5</issue>
<fpage>707</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="doi">10.3920/BM2014.0177</pub-id>
<pub-id pub-id-type="pmid">25869281</pub-id>
</element-citation>
</ref>
<ref id="CR202">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>310</volume>
<fpage>561</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.09.033</pub-id>
<pub-id pub-id-type="pmid">26408987</pub-id>
</element-citation>
</ref>
<ref id="CR203">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akbari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Asemi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Daneshvar Kakhaki</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bahmani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kouchaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tamtaji</surname>
<given-names>OR</given-names>
</name>
<name>
<surname>Hamidi</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Salami</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial</article-title>
<source/>Frontiers in aging neuroscience
          <year>2016</year>
<volume>8</volume>
<fpage>256</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2016.00256</pub-id>
<pub-id pub-id-type="pmid">27891089</pub-id>
</element-citation>
</ref>
<ref id="CR204">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kountouras</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boziki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gavalas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zavos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grigoriadis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Deretzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tzilves</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Katsinelos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tsolaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chatzopoulos</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease</article-title>
<source/>Journal of neurology
          <year>2009</year>
<volume>256</volume>
<issue>5</issue>
<fpage>758</fpage>
<lpage>767</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-009-5011-z</pub-id>
<pub-id pub-id-type="pmid">19240960</pub-id>
</element-citation>
</ref>
<ref id="CR205">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Feher</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scuderi</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dobolyi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cservenak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Juhasz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ligeti</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pongor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gomez-Cabrera</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: role of microbiome</article-title>
<source/>Experimental gerontology
          <year>2019</year>
<volume>115</volume>
<fpage>122</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.exger.2018.12.005</pub-id>
<pub-id pub-id-type="pmid">30529024</pub-id>
</element-citation>
</ref>
<ref id="CR206">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Logroscino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jick</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Hernan</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study</article-title>
<source/>European journal of neurology
          <year>2009</year>
<volume>16</volume>
<issue>6</issue>
<fpage>745</fpage>
<lpage>751</lpage>
<pub-id pub-id-type="doi">10.1111/j.1468-1331.2009.02586.x</pub-id>
<pub-id pub-id-type="pmid">19475756</pub-id>
</element-citation>
</ref>
<ref id="CR207">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cashman</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Krewski</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis</article-title>
<source/>Neurotoxicology
          <year>2017</year>
<volume>61</volume>
<fpage>101</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2016.06.015</pub-id>
<pub-id pub-id-type="pmid">27377857</pub-id>
</element-citation>
</ref>
<ref id="CR208">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>D'Aigle</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gowing</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Julien</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Rivest</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis</article-title>
<source/>The Journal of neuroscience : the official journal of the Society for Neuroscience
          <year>2004</year>
<volume>24</volume>
<issue>6</issue>
<fpage>1340</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4786-03.2004</pub-id>
<pub-id pub-id-type="pmid">14960605</pub-id>
</element-citation>
</ref>
<ref id="CR209">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Gascon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Champion</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lancero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Narvaez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Honrada</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ruvalcaba</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)</article-title>
<source/>Journal of neuroimmunology
          <year>2009</year>
<volume>206</volume>
<issue>1-2</issue>
<fpage>121</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.09.017</pub-id>
<pub-id pub-id-type="pmid">19013651</pub-id>
</element-citation>
</ref>
<ref id="CR210">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Longstreth</surname>
<given-names>WT</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Meschke</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Smoot</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Smoot</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Koepsell</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS</article-title>
<source/>Medical hypotheses
          <year>2005</year>
<volume>64</volume>
<issue>6</issue>
<fpage>1153</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2004.07.041</pub-id>
<pub-id pub-id-type="pmid">15823706</pub-id>
</element-citation>
</ref>
<ref id="CR211">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaneko</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hachiya</surname>
<given-names>NS</given-names>
</name>
</person-group>
<article-title>Hypothesis: gut as source of motor neuron toxin in the development of ALS</article-title>
<source/>Medical hypotheses
          <year>2006</year>
<volume>66</volume>
<issue>2</issue>
<fpage>438</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2005.09.012</pub-id>
<pub-id pub-id-type="pmid">16236460</pub-id>
</element-citation>
</ref>
<ref id="CR212">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Asmakh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hedin</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Microbiota and the control of blood-tissue barriers</article-title>
<source/>Tissue barriers
          <year>2015</year>
<volume>3</volume>
<issue>3</issue>
<fpage>e1039691</fpage>
<pub-id pub-id-type="doi">10.1080/21688370.2015.1039691</pub-id>
<pub-id pub-id-type="pmid">26451344</pub-id>
</element-citation>
</ref>
<ref id="CR213">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Shaoping</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>Jianxun</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Yong-guo</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Jingsong</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Jun</given-names>
</name>
</person-group>
<article-title>Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model</article-title>
<source/>Physiological Reports
          <year>2015</year>
<volume>3</volume>
<issue>4</issue>
<fpage>e12356</fpage>
<pub-id pub-id-type="doi">10.14814/phy2.12356</pub-id>
<pub-id pub-id-type="pmid">25847918</pub-id>
</element-citation>
</ref>
<ref id="CR214">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing</article-title>
<source/>Frontiers in microbiology
          <year>2016</year>
<volume>7</volume>
<fpage>1479</fpage>
<pub-id pub-id-type="pmid">27703453</pub-id>
</element-citation>
</ref>
<ref id="CR215">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brenner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hiergeist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gessner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ludolph</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Weishaupt</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>The fecal microbiome of ALS patients</article-title>
<source/>Neurobiology of aging
          <year>2018</year>
<volume>61</volume>
<fpage>132</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.09.023</pub-id>
<pub-id pub-id-type="pmid">29065369</pub-id>
</element-citation>
</ref>
<ref id="CR216">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis</article-title>
<source/>Clinical therapeutics
          <year>2017</year>
<volume>39</volume>
<issue>2</issue>
<fpage>322</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2016.12.014</pub-id>
<pub-id pub-id-type="pmid">28129947</pub-id>
</element-citation>
</ref>
<ref id="CR217">
<label>217.</label>
<mixed-citation publication-type="other">Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gaggia F, Lucenti A, Bersano E, et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies, Journal of clinical gastroenterology. 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition &amp; Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:2018, S68–S70.</mixed-citation>
</ref>
<ref id="CR218">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The gut microbiome in human neurological disease: a review</article-title>
<source/>Annals of neurology
          <year>2017</year>
<volume>81</volume>
<issue>3</issue>
<fpage>369</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1002/ana.24901</pub-id>
<pub-id pub-id-type="pmid">28220542</pub-id>
</element-citation>
</ref>
<ref id="CR219">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kalari</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Novotna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paz Soldan</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Luckey</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Marietta</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Jeraldo</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls</article-title>
<source/>Scientific reports
          <year>2016</year>
<volume>6</volume>
<fpage>28484</fpage>
<pub-id pub-id-type="doi">10.1038/srep28484</pub-id>
<pub-id pub-id-type="pmid">27346372</pub-id>
</element-citation>
</ref>
<ref id="CR220">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buscarinu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Cerasoli</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Annibali</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Policano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lionetto</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Capi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mechelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fornasiero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mattei</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study</article-title>
<source/>Multiple sclerosis
          <year>2017</year>
<volume>23</volume>
<issue>3</issue>
<fpage>442</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1177/1352458516652498</pub-id>
<pub-id pub-id-type="pmid">27270497</pub-id>
</element-citation>
</ref>
<ref id="CR221">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dendrou</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Fugger</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Friese</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Immunopathology of multiple sclerosis</article-title>
<source/>Nat Rev Immunol
          <year>2015</year>
<volume>15</volume>
<issue>9</issue>
<fpage>545</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.1038/nri3871</pub-id>
<pub-id pub-id-type="pmid">26250739</pub-id>
</element-citation>
</ref>
<ref id="CR222">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives</article-title>
<source/>Mediators of inflammation
          <year>2018</year>
<volume>2018</volume>
<fpage>8168717</fpage>
<pub-id pub-id-type="doi">10.1155/2018/8168717</pub-id>
<pub-id pub-id-type="pmid">29805314</pub-id>
</element-citation>
</ref>
<ref id="CR223">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ezendam</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Klerk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gremmer</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>van Loveren</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents</article-title>
<source/>Clinical and experimental immunology
          <year>2008</year>
<volume>154</volume>
<issue>3</issue>
<fpage>424</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03788.x</pub-id>
<pub-id pub-id-type="pmid">19037925</pub-id>
</element-citation>
</ref>
<ref id="CR224">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okuno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moriya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Honorat</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kumanogoh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kayama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells</article-title>
<source/>PloS one
          <year>2011</year>
<volume>6</volume>
<issue>11</issue>
<fpage>e27644</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0027644</pub-id>
<pub-id pub-id-type="pmid">22110705</pub-id>
</element-citation>
</ref>
<ref id="CR225">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremlett</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Faruqi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roalstad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Graves</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Waubant</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Centers USNoPM: Gut microbiota composition and relapse risk in pediatric MS: a pilot study</article-title>
<source/>Journal of the neurological sciences
          <year>2016</year>
<volume>363</volume>
<fpage>153</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2016.02.042</pub-id>
<pub-id pub-id-type="pmid">27000242</pub-id>
</element-citation>
</ref>
<ref id="CR226">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamczyk-Sowa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Medrek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Madej</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Michlicka</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dobrakowski</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Does the gut microbiota influence immunity and inflammation in multiple sclerosis pathophysiology?</article-title>
<source/>Journal of immunology research
          <year>2017</year>
<volume>2017</volume>
<fpage>7904821</fpage>
<pub-id pub-id-type="doi">10.1155/2017/7904821</pub-id>
<pub-id pub-id-type="pmid">28316999</pub-id>
</element-citation>
</ref>
<ref id="CR227">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa-Reparaz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mielcarz</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Ditrio</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Burroughs</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Foureau</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Haque-Begum</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>LH</given-names>
</name>
</person-group>
<article-title>Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis</article-title>
<source/>Journal of immunology
          <year>2009</year>
<volume>183</volume>
<issue>10</issue>
<fpage>6041</fpage>
<lpage>6050</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.0900747</pub-id>
</element-citation>
</ref>
<ref id="CR228">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bron</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Mercenier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Garcia-Rodenas</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Can probiotics modulate human disease by impacting intestinal barrier function?</article-title>
<source/>The British journal of nutrition
          <year>2017</year>
<volume>117</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114516004037</pub-id>
<pub-id pub-id-type="pmid">28102115</pub-id>
</element-citation>
</ref>
<ref id="CR229">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wing</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Kremenchutzky</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?</article-title>
<source/>Beneficial microbes
          <year>2019</year>
<volume>10</volume>
<issue>1</issue>
<fpage>27</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.3920/BM2018.0029</pub-id>
<pub-id pub-id-type="pmid">30525949</pub-id>
</element-citation>
</ref>
<ref id="CR230">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Mota</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Montenegro</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Burbano</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Seabra</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Lobo Filho</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>DL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular analysis of oral bacteria in dental biofilm and atherosclerotic plaques of patients with vascular disease</article-title>
<source/>International journal of cardiology
          <year>2014</year>
<volume>174</volume>
<issue>3</issue>
<fpage>710</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijcard.2014.04.201</pub-id>
<pub-id pub-id-type="pmid">24820755</pub-id>
</element-citation>
</ref>
<ref id="CR231">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apfalter</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hammerschlag</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Boman</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis</article-title>
<source/>Stroke
          <year>2003</year>
<volume>34</volume>
<issue>7</issue>
<fpage>e73</fpage>
<lpage>e75</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.0000079304.09344.97</pub-id>
<pub-id pub-id-type="pmid">12817098</pub-id>
</element-citation>
</ref>
<ref id="CR232">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Drautz-Moses</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Alhede</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maw</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Purbojati</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Kushwaha</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Gheorghe</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bjarnsholt</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In silico analyses of metagenomes from human atherosclerotic plaque samples</article-title>
<source/>Microbiome
          <year>2015</year>
<volume>3</volume>
<fpage>38</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-015-0100-y</pub-id>
<pub-id pub-id-type="pmid">26334731</pub-id>
</element-citation>
</ref>
<ref id="CR233">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Fak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nookaew</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tremaroli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Petranovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Backhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Symptomatic atherosclerosis is associated with an altered gut metagenome</article-title>
<source/>Nature communications
          <year>2012</year>
<volume>3</volume>
<fpage>1245</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms2266</pub-id>
<pub-id pub-id-type="pmid">23212374</pub-id>
</element-citation>
</ref>
<ref id="CR234">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ufnal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zadlo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ostaszewski</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>TMAO: a small molecule of great expectations</article-title>
<source/>Nutrition
          <year>2015</year>
<volume>31</volume>
<issue>11-12</issue>
<fpage>1317</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2015.05.006</pub-id>
<pub-id pub-id-type="pmid">26283574</pub-id>
</element-citation>
</ref>
<ref id="CR235">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skagen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Troseid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ueland</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gregersen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kummen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bjerkeli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Reier-Nilsen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis</article-title>
<source/>Atherosclerosis
          <year>2016</year>
<volume>247</volume>
<fpage>64</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2016.01.033</pub-id>
<pub-id pub-id-type="pmid">26868510</pub-id>
</element-citation>
</ref>
<ref id="CR236">
<label>236.</label>
<mixed-citation publication-type="other">Lau K, Srivatsav V, Rizwan A, Nashed A, Liu R, Shen R, Akhtar M. Bridging the gap between gut microbial dysbiosis and cardiovascular diseases. Nutrients. 2017:9(8).</mixed-citation>
</ref>
<ref id="CR237">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>WHW</given-names>
</name>
<name>
<surname>Backhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Landmesser</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Intestinal microbiota in cardiovascular health and disease: JACC State-of-the-Art Review</article-title>
<source/>Journal of the American College of Cardiology
          <year>2019</year>
<volume>73</volume>
<issue>16</issue>
<fpage>2089</fpage>
<lpage>2105</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2019.03.024</pub-id>
<pub-id pub-id-type="pmid">31023434</pub-id>
</element-citation>
</ref>
<ref id="CR238">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiessling</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jahreis</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol</article-title>
<source/>European journal of clinical nutrition
          <year>2002</year>
<volume>56</volume>
<issue>9</issue>
<fpage>843</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejcn.1601399</pub-id>
<pub-id pub-id-type="pmid">12209372</pub-id>
</element-citation>
</ref>
<ref id="CR239">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rerksuppaphol</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rerksuppaphol</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A randomized double-blind controlled trial of Lactobacillus acidophilus plus Bifidobacterium bifidum versus placebo in patients with hypercholesterolemia</article-title>
<source/>Journal of clinical and diagnostic research : JCDR
          <year>2015</year>
<volume>9</volume>
<issue>3</issue>
<fpage>KC01</fpage>
<lpage>KC04</lpage>
<pub-id pub-id-type="pmid">25954637</pub-id>
</element-citation>
</ref>
<ref id="CR240">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice</article-title>
<source/>Food &amp; function
          <year>2018</year>
<volume>9</volume>
<issue>8</issue>
<fpage>4299</fpage>
<lpage>4309</lpage>
<pub-id pub-id-type="doi">10.1039/C8FO00349A</pub-id>
<pub-id pub-id-type="pmid">30039147</pub-id>
</element-citation>
</ref>
<ref id="CR241">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benakis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Caballero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faraco</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sita</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Racchumi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pamer</surname>
<given-names>EG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells</article-title>
<source/>Nature medicine
          <year>2016</year>
<volume>22</volume>
<issue>5</issue>
<fpage>516</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4068</pub-id>
<pub-id pub-id-type="pmid">27019327</pub-id>
</element-citation>
</ref>
<ref id="CR242">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pussinen</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Alfthan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jousilahti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Paju</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tuomilehto</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Systemic exposure to Porphyromonas gingivalis predicts incident stroke</article-title>
<source/>Atherosclerosis
          <year>2007</year>
<volume>193</volume>
<issue>1</issue>
<fpage>222</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2006.06.027</pub-id>
<pub-id pub-id-type="pmid">16872615</pub-id>
</element-citation>
</ref>
<ref id="CR243">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ooshima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maeno</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Continual Gram-negative bacterial challenge accelerates stroke onset in stroke-prone spontaneously hypertensive rats</article-title>
<source/>Clinical and experimental hypertension
          <year>2013</year>
<volume>35</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.3109/10641963.2012.689042</pub-id>
<pub-id pub-id-type="pmid">22630606</pub-id>
</element-citation>
</ref>
<ref id="CR244">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>WHW</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects</article-title>
<source/>Circulation
          <year>2017</year>
<volume>135</volume>
<issue>17</issue>
<fpage>1671</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.025338</pub-id>
<pub-id pub-id-type="pmid">28438808</pub-id>
</element-citation>
</ref>
<ref id="CR245">
<label>245.</label>
<mixed-citation publication-type="other">Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT, Zhu JJ, You C, Chen Q, Zhou L, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. Journal of the American Heart Association. 2015:4(11).</mixed-citation>
</ref>
<ref id="CR246">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shikata</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ikedo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Korai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kotoda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yokosuka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Potential influences of gut microbiota on the formation of intracranial aneurysm</article-title>
<source/>Hypertension
          <year>2019</year>
<volume>73</volume>
<issue>2</issue>
<fpage>491</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.118.11804</pub-id>
<pub-id pub-id-type="pmid">30624992</pub-id>
</element-citation>
</ref>
<ref id="CR247">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zalvide</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faurobert</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Albiges-Rizo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tournier-Lasserve</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis</article-title>
<source/>Trends in molecular medicine
          <year>2013</year>
<volume>19</volume>
<issue>5</issue>
<fpage>302</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2013.02.004</pub-id>
<pub-id pub-id-type="pmid">23506982</pub-id>
</element-citation>
</ref>
<ref id="CR248">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kotzin</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Hobson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zeineddine</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Lightle</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Endothelial TLR4 and the microbiome drive cerebral cavernous malformations</article-title>
<source/>Nature
          <year>2017</year>
<volume>545</volume>
<issue>7654</issue>
<fpage>305</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1038/nature22075</pub-id>
<pub-id pub-id-type="pmid">28489816</pub-id>
</element-citation>
</ref>
<ref id="CR249">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Koduah</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heimesaat</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bereswill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dames</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kershaw</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Curato</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke</article-title>
<source/>Stroke
          <year>2016</year>
<volume>47</volume>
<issue>5</issue>
<fpage>1354</fpage>
<lpage>1363</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.115.011800</pub-id>
<pub-id pub-id-type="pmid">27056982</pub-id>
</element-citation>
</ref>
<ref id="CR250">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boumis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Capone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galati</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Venditti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Petrosillo</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Probiotics and infective endocarditis in patients with hereditary hemorrhagic` telangiectasia: a clinical case and a review of the literature</article-title>
<source/>BMC Infect Dis
          <year>2018</year>
<volume>18</volume>
<issue>1</issue>
<fpage>65</fpage>
<pub-id pub-id-type="doi">10.1186/s12879-018-2956-5</pub-id>
<pub-id pub-id-type="pmid">29390976</pub-id>
</element-citation>
</ref>
<ref id="CR251">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Yundong</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Min</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Chun–Chia</given-names>
</name>
<name>
<surname>Gillilland</surname>
<given-names>Merritt</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Xia</given-names>
</name>
<name>
<surname>El–Zaatari</surname>
<given-names>Mohamad</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>Gary B.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>Vincent B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Jiajie</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Soon–Cheol</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Yu–Ming</given-names>
</name>
<name>
<surname>Gumucio</surname>
<given-names>Deborah L.</given-names>
</name>
<name>
<surname>Owyang</surname>
<given-names>Chung</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>John Y.</given-names>
</name>
</person-group>
<article-title>Stress-Induced Corticotropin-Releasing Hormone-Mediated NLRP6 Inflammasome Inhibition and Transmissible Enteritis in Mice</article-title>
<source/>Gastroenterology
          <year>2013</year>
<volume>144</volume>
<issue>7</issue>
<fpage>1478-1487.e8</fpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2013.02.038</pub-id>
<pub-id pub-id-type="pmid">23470617</pub-id>
</element-citation>
</ref>
<ref id="CR252">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Joossens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vieira-Silva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Darzi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kurilshikov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonder</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Valles-Colomer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vandeputte</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Population-level analysis of gut microbiome variation</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<issue>6285</issue>
<fpage>560</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad3503</pub-id>
<pub-id pub-id-type="pmid">27126039</pub-id>
</element-citation>
</ref>
<ref id="CR253">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothschild</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weissbrod</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kurilshikov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zeevi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Costea</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Godneva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kalka</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Bar</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<issue>7695</issue>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature25973</pub-id>
<pub-id pub-id-type="pmid">29489753</pub-id>
</element-citation>
</ref>
<ref id="CR254">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhernakova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kurilshikov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonder</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Tigchelaar</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Schirmer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vatanen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mujagic</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vila</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vieira-Silva</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<issue>6285</issue>
<fpage>565</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad3369</pub-id>
<pub-id pub-id-type="pmid">27126040</pub-id>
</element-citation>
</ref>
<ref id="CR255">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonsson</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Backhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Role of gut microbiota in atherosclerosis</article-title>
<source/>Nature reviews Cardiology
          <year>2017</year>
<volume>14</volume>
<issue>2</issue>
<fpage>79</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1038/nrcardio.2016.183</pub-id>
<pub-id pub-id-type="pmid">27905479</pub-id>
</element-citation>
</ref>
<ref id="CR256">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nery</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Urich</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Breschi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Dobin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zaleski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Beer</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>WC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of the transcriptional landscapes between human and mouse tissues</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2014</year>
<volume>111</volume>
<issue>48</issue>
<fpage>17224</fpage>
<lpage>17229</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1413624111</pub-id>
<pub-id pub-id-type="pmid">25413365</pub-id>
</element-citation>
</ref>
<ref id="CR257">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouse Genome Sequencing</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Waterston</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Lindblad-Toh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Birney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abril</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Agarwala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ainscough</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alexandersson</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Initial sequencing and comparative analysis of the mouse genome</article-title>
<source/>Nature
          <year>2002</year>
<volume>420</volume>
<issue>6915</issue>
<fpage>520</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1038/nature01262</pub-id>
<pub-id pub-id-type="pmid">12466850</pub-id>
</element-citation>
</ref>
<ref id="CR258">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Church</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Goodstadt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hillier</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Zody</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>She</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bult</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Agarwala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>DiCuccio</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lineage-specific biology revealed by a finished genome assembly of the mouse</article-title>
<source/>PLoS biology
          <year>2009</year>
<volume>7</volume>
<issue>5</issue>
<fpage>e1000112</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000112</pub-id>
<pub-id pub-id-type="pmid">19468303</pub-id>
</element-citation>
</ref>
<ref id="CR259">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hugenholtz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>Mouse models for human intestinal microbiota research: a critical evaluation</article-title>
<source/>Cellular and molecular life sciences : CMLS
          <year>2018</year>
<volume>75</volume>
<issue>1</issue>
<fpage>149</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-017-2693-8</pub-id>
<pub-id pub-id-type="pmid">29124307</pub-id>
</element-citation>
</ref>
<ref id="CR260">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholtens</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Oozeer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Knol</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The early settlers: intestinal microbiology in early life</article-title>
<source/>Annual review of food science and technology
          <year>2012</year>
<volume>3</volume>
<fpage>425</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-food-022811-101120</pub-id>
<pub-id pub-id-type="pmid">22224552</pub-id>
</element-citation>
</ref>
<ref id="CR261">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeevi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Israeli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rothschild</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ben-Yacov</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lador</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Avnit-Sagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lotan-Pompan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Personalized Nutrition by Prediction of Glycemic Responses</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<issue>5</issue>
<fpage>1079</fpage>
<lpage>1094</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.001</pub-id>
<pub-id pub-id-type="pmid">26590418</pub-id>
</element-citation>
</ref>
<ref id="CR262">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costea</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sunagawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tramontano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Driessen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hercog</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>FE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Towards standards for human fecal sample processing in metagenomic studies</article-title>
<source/>Nature biotechnology
          <year>2017</year>
<volume>35</volume>
<issue>11</issue>
<fpage>1069</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3960</pub-id>
<pub-id pub-id-type="pmid">28967887</pub-id>
</element-citation>
</ref>
<ref id="CR263">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franzosa</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Segata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Waldron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Earl</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Giannoukos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Boylan</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Ciulla</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relating the metatranscriptome and metagenome of the human gut</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2014</year>
<volume>111</volume>
<issue>22</issue>
<fpage>E2329</fpage>
<lpage>E2338</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1319284111</pub-id>
<pub-id pub-id-type="pmid">24843156</pub-id>
</element-citation>
</ref>
<ref id="CR264">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Abu-Ali</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vogtmann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fodor</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Amir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schwager</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Microbiome Quality Control Project C et al: Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium</article-title>
<source/>Nature biotechnology
          <year>2017</year>
<volume>35</volume>
<issue>11</issue>
<fpage>1077</fpage>
<lpage>1086</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3981</pub-id>
<pub-id pub-id-type="pmid">28967885</pub-id>
</element-citation>
</ref>
<ref id="CR265">
<label>265.</label>
<mixed-citation publication-type="other">Shah N, Tang H, Doak TG, Ye Y. Comparing bacterial communities inferred from 16S rRNA gene sequencing and shotgun metagenomics. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. 2011:165–76.</mixed-citation>
</ref>
<ref id="CR266">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steven</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gallegos-Graves</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Starkenburg</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Chain</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Kuske</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Targeted and shotgun metagenomic approaches provide different descriptions of dryland soil microbial communities in a manipulated field study</article-title>
<source/>Environmental microbiology reports
          <year>2012</year>
<volume>4</volume>
<issue>2</issue>
<fpage>248</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1111/j.1758-2229.2012.00328.x</pub-id>
<pub-id pub-id-type="pmid">23757280</pub-id>
</element-citation>
</ref>
<ref id="CR267">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poretsky</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tsementzi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Konstantinidis</surname>
<given-names>KT</given-names>
</name>
</person-group>
<article-title>Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics</article-title>
<source/>PloS one
          <year>2014</year>
<volume>9</volume>
<issue>4</issue>
<fpage>e93827</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0093827</pub-id>
<pub-id pub-id-type="pmid">24714158</pub-id>
</element-citation>
</ref>
<ref id="CR268">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meisel</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hannigan</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Tyldsley</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>SanMiguel</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hodkinson</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Grice</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Skin microbiome surveys are strongly influenced by experimental design</article-title>
<source/>The Journal of investigative dermatology
          <year>2016</year>
<volume>136</volume>
<issue>5</issue>
<fpage>947</fpage>
<lpage>956</lpage>
<pub-id pub-id-type="doi">10.1016/j.jid.2016.01.016</pub-id>
<pub-id pub-id-type="pmid">26829039</pub-id>
</element-citation>
</ref>
<ref id="CR269">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Pasolli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tolio</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zolfo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asnicar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Truong</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Tett</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Segata</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Strain-level microbial epidemiology and population genomics from shotgun metagenomics</article-title>
<source/>Nature methods
          <year>2016</year>
<volume>13</volume>
<issue>5</issue>
<fpage>435</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.3802</pub-id>
<pub-id pub-id-type="pmid">26999001</pub-id>
</element-citation>
</ref>
<ref id="CR270">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Meisel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dirnagl</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Gut microbiota impact on stroke outcome: fad or fact?</article-title>
<source/>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
          <year>2016</year>
<volume>36</volume>
<issue>5</issue>
<fpage>891</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="doi">10.1177/0271678X16636890</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>